Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3045066	s-tymidk	u/l (u/l)	943	1791	0.11%
3045066	s-tymidk	— (—)	175	219	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Non-follicular lymphoma, hilmo, excluding all cancers

190

40.06

311.37

3.5

1.5

54.78

48.87

u/l

0.07

180

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

257

40.84

307.65

3.3

1.4

46.58

39.46

u/l

0.11

242

Primary_lymphoid and hematopoietic malignant neoplasms

389

137

29.47

307.65

2.9

1.3

53.82

28.94

u/l

1.03

367

121

Primary_lymphoid and hematopoietic malignant neoplasms

389

123

32.81

307.65

2.9

1.4

53.82

40.41

u/l

0.36

367

112

Enlarged lymph nodes

239

26.52

307.65

2.0

2.1

27.38

22.47

u/l

0.22

227

Fever of other and unknown origin

288

321

8.38

213.22

2.0

1.9

48.77

30.78

u/l

0.87

265

286

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

156

21.91

210.44

3.0

1.4

43.22

37.29

u/l

0.10

151

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

429

563

5.49

193.96

2.0

1.9

41.30

35.24

u/l

0.28

398

498

Secondary uncertain malignant neoplasm

153

112

14.05

165.80

3.1

1.8

46.96

58.42

u/l

0.19

148

104

Bacterial infection, other or unspecified

275

407

6.15

152.89

2.2

2.0

50.22

26.50

u/l

1.66

253

374

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

206

231

7.90

141.85

2.8

1.4

43.73

36.71

u/l

0.22

199

206

General symptoms and signs

375

385

4.90

128.46

1.9

2.0

45.56

30.82

u/l

0.69

339

341

Malignant neoplasm

329

404

4.85

120.74

2.3

1.4

43.81

28.26

u/l

0.79

301

356

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

318

395

4.78

114.69

2.3

1.4

43.95

30.86

u/l

0.59

294

344

Malignant neoplasm, wide definition for exclusion

318

395

4.78

114.69

2.3

1.4

43.95

30.86

u/l

0.59

294

344

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

318

395

4.78

114.68

2.3

1.4

43.95

30.86

u/l

0.59

294

344

Other diseases of blood and blood-forming organs, wide

149

197

7.67

105.82

2.4

1.8

60.76

35.03

u/l

0.72

143

178

Other bacterial diseases

342

605

3.93

103.83

2.0

57.84

28.06

u/l

1.96

309

550

Any event in cancer register

309

424

4.34

100.21

2.4

1.3

44.04

25.06

u/l

1.04

283

369

First line medication for Crohn's disease

362

515

3.85

97.84

1.8

2.0

41.35

37.26

u/l

0.15

327

462

ILD medications

368

541

3.75

96.35

1.8

2.0

42.38

35.52

u/l

0.28

330

487

ILD medications: prednisolone, methylprednisolone, prednisone

358

536

3.79

96.18

1.8

2.0

42.62

35.77

u/l

0.27

324

482

Oral corticosteroids

360

595

3.67

95.34

1.8

2.0

35.66

40.36

u/l

0.20

332

530

Inflammatory bowel disease treatment related agents

349

609

3.27

76.40

1.8

2.0

36.00

39.88

u/l

0.15

320

542

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

287

503

3.59

74.67

2.0

1.8

46.68

34.05

u/l

0.56

263

443

287

503

3.59

74.67

2.0

1.8

46.68

34.05

u/l

0.56

263

443

Neoplasms

202

228

4.76

69.73

1.8

1.3

33.43

24.72

u/l

0.38

187

195

Influenza and pneumonia

318

667

3.14

69.06

2.0

1.9

44.55

34.12

u/l

0.50

291

593

Pneumonias (Asthma/COPD co-morbidities)

305

667

3.18

68.49

2.0

1.9

45.87

33.29

u/l

0.62

281

593

All pneumoniae

306

674

3.14

67.45

2.0

1.9

45.68

33.59

u/l

0.59

282

600

Systemic connective tissue disorders

148

304

4.90

67.32

1.6

2.1

17.78

39.70

u/l

1.67

134

276

ILD medications: immunosuppressive drugs

190

459

3.99

65.76

1.7

2.1

25.79

37.01

u/l

0.78

162

411

Pneumonia, organism unspecified

277

634

3.17

62.85

2.0

47.78

34.86

u/l

0.58

254

566

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

291

683

3.00

59.89

2.0

1.9

47.55

33.18

u/l

0.72

268

610

Medical observation and evaluation for suspected diseases and conditions

230

312

3.79

59.67

2.3

1.5

37.89

33.61

u/l

0.14

211

276

Any gastric operation

204

244

4.21

59.64

1.8

1.6

37.34

36.61

u/l

0.02

190

221

GASTRO-related operations

204

244

4.21

59.64

1.8

1.6

37.34

36.61

u/l

0.02

190

221

Examination and observation for other reasons

200

309

3.95

58.67

2.1

1.5

27.04

33.80

u/l

0.37

187

274

Malaise and fatigue

147

268

4.59

58.34

1.9

2.0

34.20

24.89

u/l

0.47

134

240

Certain disorders involving the immune mechanism

173

5.66

51.82

1.7

2.0

16.40

49.12

u/l

1.47

160

Other systemic involvement of connective tissue (FG)

103

195

5.28

51.03

1.6

2.1

18.89

35.31

u/l

1.21

181

Certain infectious and parasitic diseases

268

448

3.00

49.43

1.8

2.0

41.77

30.72

u/l

0.45

238

403

Other medical care

142

354

3.94

48.68

2.5

1.9

61.31

29.40

u/l

1.19

134

322

Aplastic and other anaemias

155

398

3.71

48.46

1.9

2.0

41.77

40.01

u/l

0.05

144

371

Persons encountering health services for specific procedures and health care

290

669

2.69

47.49

2.0

1.9

55.65

28.79

u/l

1.41

262

603

Other anaemias

144

375

3.72

45.50

1.9

2.0

43.22

41.86

u/l

0.03

134

349

Other and unspecified anaemias

143

374

3.72

45.12

1.9

2.0

43.48

41.96

u/l

0.04

133

348

COPD/asthma related infections

278

504

2.77

44.76

2.1

1.8

37.22

34.08

u/l

0.11

261

444

COPD/asthma/ILD related infections

278

504

2.77

44.76

2.1

1.8

37.22

34.08

u/l

0.11

261

444

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

200

631

2.95

43.10

2.1

2.0

24.54

45.56

u/l

1.84

182

572

Other systemic involvement of connective tissue

105

243

4.35

41.42

1.6

2.0

18.69

44.13

u/l

1.53

220

COPD differential diagnosis

206

330

3.13

40.78

1.7

1.9

39.15

41.75

u/l

0.06

191

293

ILD differential diagnosis

206

330

3.13

40.78

1.7

1.9

39.15

41.75

u/l

0.06

191

293

Excluding asthma or asthma-COPD overlap

207

333

3.12

40.72

1.7

1.9

39.19

41.39

u/l

0.05

191

296

Abnormal findings on diagnostic imaging of lung

155

480

3.16

38.12

2.1

2.0

24.72

44.98

u/l

1.39

140

438

Autoimmune diseases excluding thyroid diseases, strict definition

265

581

2.55

37.94

1.6

2.0

27.43

44.22

u/l

1.06

237

532

Benign neoplasms

165

282

3.32

37.32

1.9

1.3

34.45

30.82

u/l

0.10

148

244

Infections, IBD-co-morbidities

6.90

36.92

2.1

2.3

39.60

73.10

u/l

0.42

Autoimmune diseases excluding thyroid diseases

269

600

2.49

36.90

1.6

2.0

27.70

43.37

u/l

0.99

241

549

Autoimmune diseases related-to ILD

224

777

2.54

36.08

1.7

2.0

20.20

39.86

u/l

2.79

198

704

Finngen Rheumatological endpoints

248

561

2.53

35.22

1.7

2.0

43.33

40.42

u/l

0.08

221

508

Septicaemia

119

324

3.55

35.11

2.2

2.0

66.30

28.01

u/l

1.02

107

297

Other pulmonary diagnosis

195

333

2.94

34.95

1.8

1.9

40.67

41.39

u/l

0.02

180

296

Symptoms and signs involving the skin and subcutaneous tissue

190

714

2.66

34.37

2.2

1.9

39.44

36.51

u/l

0.09

172

638

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

5.20

33.51

1.8

2.1

43.40

38.07

u/l

0.07

Used for control exclusion in common control thyroid runs

260

552

2.39

31.93

1.7

2.0

29.40

45.37

u/l

0.91

232

506

Any reimbursement code in KELA

122

166

3.69

30.63

1.8

1.5

42.10

18.42

u/l

0.92

116

145

Explicit Sepsis

127

394

3.10

30.33

2.2

1.9

64.37

34.06

u/l

0.77

114

359

Coagulation defects, purpura and other haemorrhagic conditions

179

4.33

30.32

1.7

2.0

15.95

47.86

u/l

1.49

164

Polyarthropathies

189

483

2.61

30.17

2.0

33.32

41.66

u/l

0.35

167

438

Autoimmune diseases

268

601

2.28

29.81

1.8

2.0

28.08

43.33

u/l

0.92

237

550

L04AX Other immunosuppressants

151

560

2.70

28.44

1.7

2.0

22.10

41.41

u/l

1.93

128

510

Sarcoidosis

124

4.96

28.33

1.5

1.9

16.71

59.96

u/l

1.39

117

Second line medication for Crohn's disease

153

579

2.65

27.71

1.7

2.0

22.50

40.44

u/l

1.79

130

527

Infections of the skin and subcutaneous tissue

152

587

2.59

26.21

2.2

1.8

25.06

40.18

u/l

1.13

142

527

Other septicaemia

287

3.26

24.88

2.4

2.0

77.70

27.55

u/l

1.13

266

Headache

119

343

2.90

24.67

1.7

1.9

37.79

22.68

u/l

0.43

106

300

Bacterial Sepsis

125

408

2.73

23.54

1.8

2.0

69.21

33.78

u/l

0.94

113

378

259

661

2.07

23.26

2.0

1.9

31.46

41.53

u/l

0.51

241

587

Diseases of the skin and subcutaneous tissue

235

548

2.15

22.91

2.0

1.8

42.16

41.41

u/l

0.02

214

489

ILD medications: azathioprine

5.46

22.85

2.1

1.8

27.57

18.21

u/l

0.49

Diagnoses used for exclusion with ILD

269

3.25

22.79

1.6

2.0

18.51

40.51

u/l

1.40

247

Localized swelling, mass and lump of skin and subcutaneous tissue

293

3.12

22.29

2.6

1.8

48.62

26.68

u/l

0.46

262

Cardiovascular diseases

131

258

2.77

22.09

1.7

1.8

36.64

34.89

u/l

0.04

122

220

Reimbursement for rheumatic diseases

147

614

2.40

21.65

1.7

2.0

34.19

35.19

u/l

0.03

130

558

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

118

4.21

21.37

2.3

1.5

17.11

42.35

u/l

0.99

108

Oxycodone

105

362

2.82

21.33

2.2

2.1

74.35

36.35

u/l

0.84

334

Asthma, unspecified (mode), excluding more controls

106

292

2.86

21.06

1.6

1.9

16.81

44.02

u/l

1.85

259

Asthma, unspecified (mode)

108

310

2.77

20.32

1.6

1.9

16.87

43.73

u/l

1.98

275

Asthma

151

330

2.46

20.23

1.6

1.9

15.29

41.75

u/l

2.16

136

293

Oedema, not elsewhere classified

189

3.54

20.10

1.7

2.0

30.24

24.31

u/l

0.32

173

Pain in throat and chest

197

564

2.14

20.01

2.0

1.9

42.98

37.23

u/l

0.15

179

502

Bronchitis

235

778

1.98

19.94

1.9

29.84

40.18

u/l

0.56

217

697

Asthma, excluding more controls

144

309

2.49

19.74

1.6

1.9

15.67

42.24

u/l

1.97

129

274

Cardiovascular diseases (excluding rheumatic etc)

134

305

2.54

19.65

1.7

1.8

36.43

36.37

u/l

0.00

124

261

Abnormal findings on examination of blood, without diagnosis

128

496

2.42

19.15

1.7

2.0

50.57

41.75

u/l

0.19

112

455

Azathioprine

4.65

19.10

2.1

1.7

27.57

23.59

u/l

0.14

Other heart diseases, wide

200

606

2.05

18.37

1.7

1.9

55.76

32.36

u/l

0.79

181

539

Other special examinations and investigations of persons without complaint or reported diagnosis

147

312

2.39

18.27

2.0

1.5

32.80

33.61

u/l

0.03

137

276

Pain, not elsewhere classified

155

3.69

18.25

1.7

2.0

25.66

20.45

u/l

0.29

141

Diseases of the respiratory system

147

309

2.39

18.20

1.8

1.9

46.91

39.14

u/l

0.16

136

271

Viral infections characterized by skin and mucous membrane lesions

106

416

2.55

18.02

2.3

1.8

32.47

35.97

u/l

0.11

378

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

103

261

2.70

17.87

2.2

1.4

18.62

34.45

u/l

1.19

231

Speech therapy

263

2.98

17.75

2.4

2.0

16.20

40.63

u/l

1.64

240

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

106

252

2.67

17.66

2.0

29.83

40.82

u/l

0.33

216

Heart failure, not strict

176

583

2.09

17.35

2.0

1.9

33.85

44.59

u/l

0.44

160

522

Persons encountering health services for other counselling and medical advice, not elsewhere classified

239

721

1.89

17.22

2.0

1.9

35.81

40.12

u/l

0.20

225

646

Other and unspecified dermatitis

122

526

2.33

16.95

1.9

37.97

37.18

u/l

0.02

107

478

Renal tubulo-interstitial diseases

190

733

1.99

16.94

1.7

2.0

67.72

30.52

u/l

1.46

169

664

Bacterial pneumonia (organism specified)

109

408

2.44

16.55

1.8

1.9

36.26

44.80

u/l

0.33

103

374

Implicit Sepsis

163

611

2.08

16.38

1.8

2.0

58.26

34.90

u/l

0.74

148

550

Implicit bacterial Sepsis

359

2.54

16.34

1.9

2.0

82.12

35.27

u/l

1.04

330

Benign neoplasms

214

621

1.93

16.21

1.9

32.50

40.98

u/l

0.33

193

555

Persons encountering health services for examination and investigation

142

312

2.29

16.07

2.1

1.5

40.40

33.61

u/l

0.16

129

276

Persons encountering health services in other circumstances, wide

254

723

1.83

16.05

2.0

1.9

32.45

40.01

u/l

0.42

238

648

Dermatitis

139

648

2.15

16.02

1.8

2.0

35.38

40.07

u/l

0.12

121

586

Dental caries

249

2.91

16.00

1.8

1.9

22.18

46.18

u/l

1.11

224

Asthma (mode)

137

330

2.28

15.91

1.6

1.9

16.61

41.75

u/l

1.97

122

293

Bacterial pneumonia, not elsewhere classified

296

2.64

15.63

1.9

2.0

32.77

40.69

u/l

0.28

270

Bacterial pneumoniae

322

2.56

15.60

1.8

2.0

32.84

41.86

u/l

0.35

294

Symptoms and signs involving the digestive system and abdomen

225

599

1.88

15.56

1.9

41.04

39.19

u/l

0.05

206

547

Symptoms and signs involving the circulatory and respiratory systems

218

575

1.90

15.52

1.7

1.9

36.73

36.85

u/l

0.00

198

511

Other heart diseases

100

261

2.54

15.29

1.7

2.0

57.62

39.89

u/l

0.30

226

Opioids

212

586

1.90

15.26

1.8

1.9

42.11

36.71

u/l

0.16

191

527

Gout

259

2.76

15.16

2.6

2.2

32.14

47.82

u/l

0.61

240

Acute upper respiratory infections of multiple and unspecified sites

154

563

2.05

14.93

1.9

1.8

23.86

40.26

u/l

1.18

140

501

Provisional assignment of new diseases of uncertain etiology

101

425

2.38

14.89

2.3

1.7

42.45

33.51

u/l

0.21

384

Codes for special purposes

101

426

2.38

14.82

2.3

1.7

42.45

33.51

u/l

0.21

384

Other diseases of intestines

219

697

1.83

14.39

1.9

2.0

41.42

36.92

u/l

0.14

199

622

Chronic periapical parodontitis

213

2.97

14.36

2.0

1.9

58.32

51.29

u/l

0.07

192

Hypertension, essential

168

481

2.00

14.20

1.6

2.0

38.38

39.54

u/l

0.03

157

424

Heart failure and antihypertensive medication

166

2.87

13.93

1.8

2.2

23.35

48.97

u/l

0.95

147

Benign neoplasm of colon, rectum, anus and anal canal

260

2.50

13.91

2.0

1.4

48.67

31.65

u/l

0.34

228

Acute upper respiratory infections

214

743

1.81

13.78

2.0

1.9

25.31

40.88

u/l

1.28

197

667

Dentinal caries

212

2.92

13.72

1.9

18.52

50.96

u/l

1.50

194

Asthma (only as main-diagnosis), excluding more controls

117

309

2.26

13.65

1.4

1.9

17.60

42.24

u/l

1.72

104

274

Complications of surgical and medical care, not elsewhere classified

200

793

1.81

13.38

1.8

2.0

39.94

37.66

u/l

0.06

180

715

Dermatitis and eczema

220

818

1.77

13.28

2.0

1.9

30.10

39.25

u/l

0.44

197

739

Diseases of pulp and periapical tissues

350

2.44

13.21

1.9

2.1

45.59

51.04

u/l

0.07

311

Gout, FINNGEN

310

2.53

13.09

2.6

2.1

32.14

50.70

u/l

0.77

286

Metabolic disorders

199

681

1.82

13.08

2.2

1.9

29.86

43.35

u/l

0.60

180

615

Other diseases of pleura

109

443

2.19

12.91

2.1

2.0

33.28

43.50

u/l

0.48

412

Asthma-related infections

127

613

2.04

12.87

1.7

2.0

16.87

41.39

u/l

3.47

116

554

Asthma, hospital admission 2, infections

127

613

2.04

12.87

1.7

2.0

16.88

41.39

u/l

3.47

116

554

Benign neoplasm: Colon

242

2.54

12.82

2.0

1.4

53.25

31.02

u/l

0.41

212

Other arthritis (FG)

256

2.66

12.73

1.5

2.1

20.72

33.03

u/l

0.88

235

Parasetamol

165

437

1.93

12.41

1.7

2.0

50.12

41.75

u/l

0.21

155

387

Asthma-related pneumonia

360

2.36

12.41

1.8

2.0

16.35

38.01

u/l

2.17

331

Asthma, hospital admissions 3, pneumonia

361

2.36

12.33

1.8

2.0

16.35

37.94

u/l

2.17

332

Asthma-related pneumonia or sepsis

361

2.36

12.33

1.8

2.0

16.35

37.94

u/l

2.17

332

Abnormalities of breathing

178

573

1.85

12.25

1.9

46.28

36.93

u/l

0.25

165

509

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

236

2.45

12.15

2.3

1.4

18.81

35.96

u/l

1.14

210

Asthma (only as main-diagnosis)

117

330

2.14

12.13

1.4

1.9

17.60

41.75

u/l

1.84

104

293

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

193

740

1.77

12.01

2.0

1.9

47.37

35.80

u/l

0.33

173

668

Renal failure

102

431

2.17

11.95

1.8

2.1

79.45

34.49

u/l

1.04

393

Condition for Implicit Sepsis (Organ dysfunction codes)

170

676

1.83

11.85

1.7

2.0

60.49

33.26

u/l

0.87

153

610

Fitting and adjustment of other devices

279

2.47

11.78

2.3

1.9

47.51

31.51

u/l

0.34

259

Heart failure,strict

119

417

2.06

11.72

2.0

22.52

48.42

u/l

1.95

106

380

Other respiratory diseases principally affecting the interstitium

184

2.89

11.61

1.9

2.1

66.00

41.67

u/l

0.36

170

Intestinal infectious diseases

185

819

1.76

11.52

1.8

1.9

28.69

39.71

u/l

0.69

170

735

Care involving use of rehabilitation procedures

124

596

1.98

11.50

1.8

1.9

35.45

29.94

u/l

0.15

108

538

Venous thromboembolism

119

579

2.00

11.41

2.2

2.0

57.01

33.15

u/l

0.57

108

530

Cardiac arrhythmias

127

419

2.01

11.40

1.6

2.0

43.70

36.11

u/l

0.19

119

367

DVT of lower extremities and pulmonary embolism

431

2.18

11.36

2.2

1.9

48.43

38.61

u/l

0.21

397

Other acute lower respiratory infections

113

532

2.03

11.29

2.1

1.9

35.06

39.58

u/l

0.11

107

480

Abdominal and pelvic pain

207

599

1.74

11.27

1.9

41.38

39.19

u/l

0.06

190

547

Follow-up examination after treatment for conditions other than malignant neoplasms

239

2.33

11.04

2.0

1.5

62.01

35.54

u/l

0.51

210

Hypertension

159

485

1.86

11.04

1.6

2.0

39.51

39.33

u/l

0.00

153

427

Dyspnoea

179

782

1.76

11.04

2.0

1.9

47.70

36.35

u/l

0.33

166

700

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

223

2.49

11.04

2.2

1.4

24.10

36.20

u/l

0.66

199

Diseases of the musculoskeletal system and connective tissue

107

247

2.18

11.01

1.7

1.9

39.58

45.05

u/l

0.11

101

223

Hypertensive diseases

159

486

1.85

10.98

1.6

2.0

39.51

39.33

u/l

0.00

153

427

Pain (limb, back, neck, head abdominally)

152

401

1.90

10.97

2.2

1.9

42.11

38.44

u/l

0.08

141

367

433

2.13

10.70

1.5

1.9

16.71

33.93

u/l

1.72

386

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

100

3.35

10.69

2.0

1.5

16.28

46.87

u/l

1.05

Diseases of oesophagus, stomach and duodenum

209

754

1.69

10.68

2.0

27.10

41.09

u/l

0.88

193

676

Arthropathies

182

523

1.77

10.64

1.8

1.9

39.05

40.12

u/l

0.03

164

475

Erysipelas

102

452

2.06

10.58

2.0

42.31

31.12

u/l

0.24

414

Rheumatoid arthritis

281

2.33

10.12

1.8

1.9

42.72

37.57

u/l

0.09

258

Tramadol

154

549

1.81

10.12

1.7

2.0

37.98

37.39

u/l

0.01

138

496

Lung cancer and mesothelioma

121

3.05

10.00

2.0

2.2

15.99

40.69

u/l

1.19

109

Gastrointestinal diseases

113

278

2.04

9.94

1.8

48.59

30.42

u/l

0.41

107

250

Pure hypercholesterolaemia

153

574

1.79

9.89

2.2

2.0

33.41

47.71

u/l

0.48

139

520

Chronic kidney disease

289

2.35

9.87

1.6

2.0

59.44

29.18

u/l

0.64

265

Disorders of lipoprotein metabolism and other lipidaemias

169

610

1.74

9.86

2.2

2.0

31.42

46.42

u/l

0.58

154

554

Nutritional anaemias

479

2.01

9.78

2.3

1.9

30.54

37.22

u/l

0.31

440

Nausea and vomiting

210

2.58

9.75

1.8

1.7

27.62

35.81

u/l

0.30

193

Cellulitis

203

2.62

9.70

2.6

1.8

16.18

45.22

u/l

1.53

185

Dialysis, with operation codes

116

3.21

9.70

1.3

2.0

89.66

21.49

u/l

0.87

107

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

225

2.30

9.65

2.2

1.4

21.46

36.26

u/l

0.84

200

Melanocytic naevi

170

2.77

9.60

1.8

1.3

23.78

26.22

u/l

0.06

148

All-cause Heart Failure

123

472

1.88

9.44

2.1

22.19

46.55

u/l

2.29

110

435

L04AA Selective immunosuppressants

195

2.62

9.38

1.7

1.9

20.85

46.01

u/l

1.10

180

Heart failure, strict

124

478

1.87

9.36

2.1

22.06

46.34

u/l

2.32

111

441

Other specified/unspecified arthritis

244

2.42

9.23

1.4

2.0

22.10

34.25

u/l

0.92

223

Pain in joint

111

379

1.94

9.21

1.9

1.8

48.79

38.95

u/l

0.17

345

Diarrhoea and gastroenteritis of presumed infectious origin

131

662

1.80

9.16

1.8

1.9

17.40

36.68

u/l

2.77

119

598

Chronic periodontitis

142

2.90

9.10

2.0

1.9

70.86

54.58

u/l

0.14

128

Nephropathy related operations

121

3.07

9.07

1.3

2.1

90.48

31.30

u/l

0.71

114

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

227

2.25

9.02

2.1

1.4

21.58

36.03

u/l

0.82

202

Endocrine, nutritional and metabolic diseases

156

454

1.75

8.83

1.8

1.9

47.18

40.02

u/l

0.17

141

414

Pleural effusion

150

2.81

8.82

2.0

16.90

50.28

u/l

1.28

140

Valvular heart disease excluding rheumatic fever

366

1.96

8.56

2.2

2.0

43.21

35.81

u/l

0.14

332

Benign neoplasm of major salivary glands

4.05

8.51

3.3

1.5

15.57

44.07

u/l

0.54

Dorsalgia

192

640

1.63

8.47

1.9

35.22

36.75

u/l

0.05

177

570

Other gastritis (incl. Duodenitis)

218

2.44

8.43

1.9

21.80

35.59

u/l

0.57

200

Acute sinusitis

465

1.93

8.38

2.1

1.8

24.50

39.93

u/l

0.71

413

Other soft tissue disorders, not elsewhere classified

170

633

1.66

8.37

2.0

1.9

51.93

38.41

u/l

0.32

151

567

Other disorders of lacrimal gland

319

2.17

8.37

1.6

2.0

22.95

37.43

u/l

0.80

289

Leiomyoma of uterus

163

2.32

8.36

1.7

1.4

22.80

29.47

u/l

0.21

140

Non-rheumatic valve diseases

366

1.94

8.22

2.2

2.0

43.51

35.81

u/l

0.15

332

Convulsions, not elsewhere classified

127

2.88

8.15

1.4

1.9

66.47

21.29

u/l

0.47

116

Visual disturbances

485

1.92

8.15

1.8

1.9

29.34

37.89

u/l

0.22

445

Diseases of the eye and adnexa

156

458

1.71

8.13

1.5

2.1

35.40

37.75

u/l

0.07

143

412

Other viral diseases

253

2.29

8.05

2.2

1.7

22.56

42.16

u/l

1.02

232

Bleeding

163

723

1.64

7.96

1.8

2.0

38.48

40.87

u/l

0.09

151

653

Rheumatoid arthritis, including avohilmo

386

2.03

7.95

1.7

2.0

41.17

33.14

u/l

0.15

353

Seropositive rheumatoid arthritis

200

2.45

7.89

1.7

2.1

48.71

35.97

u/l

0.16

186

Syncope and collapse

264

2.18

7.89

1.6

2.0

51.61

26.50

u/l

0.55

240

Visual disturbances and blindness

533

1.86

7.88

1.8

1.9

31.14

39.62

u/l

0.24

486

Urticaria and erythema

347

2.08

7.88

2.0

1.8

15.81

33.33

u/l

1.50

310

Complications of medical and surgical care

138

777

1.69

7.84

1.7

2.0

50.26

35.36

u/l

0.36

126

696

Intracranial trauma

106

430

1.84

7.81

1.7

2.0

37.99

42.63

u/l

0.11

385

Codeine

171

575

1.64

7.79

1.9

47.58

36.93

u/l

0.27

161

516

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

3.87

7.68

2.1

1.2

12.70

59.90

u/l

0.88

Neurological diseases

167

511

1.65

7.66

1.7

2.0

44.43

38.76

u/l

0.14

152

458

Disorders of lacrimal system

408

1.96

7.52

1.8

2.0

20.99

35.36

u/l

1.05

372

Benign lipomatous neoplasm

164

2.57

7.48

1.9

1.4

28.68

29.07

u/l

0.01

145

Osteopathies and chondropathies

108

579

1.77

7.31

2.0

1.9

28.28

34.99

u/l

0.25

525

Disorders of eyelid, lacrimal system and orbit

158

770

1.61

7.30

1.7

2.0

20.01

41.72

u/l

3.08

141

696

Cerebrovascular diseases (FINNGEN)

199

2.20

7.21

1.6

2.0

29.17

48.48

u/l

0.65

171

Abnormalities of heart beat

316

2.07

7.20

2.2

1.9

56.94

34.74

u/l

0.35

288

Cough

397

1.94

7.19

2.0

1.9

35.91

33.63

u/l

0.07

355

Iron deficiency anaemia

398

1.94

7.12

2.3

1.9

26.23

36.25

u/l

0.57

364

Disorders of other endocrine glands

416

1.92

7.11

1.5

1.9

27.21

35.06

u/l

0.31

376

Complications of procedures, not elsewhere classified

145

772

1.62

7.06

1.7

2.0

45.62

37.59

u/l

0.18

134

695

Phlebitis and thrombophlebitis (not including DVT)

212

2.32

7.03

2.3

1.9

22.15

41.63

u/l

0.87

194

Disorders of gallbladder, biliary tract and pancreas

182

756

1.55

6.97

1.9

2.0

40.16

37.31

u/l

0.08

160

684

Heart failure and bmi 25plus

228

2.06

6.81

1.7

25.05

51.41

u/l

1.39

203

Other and unspecified iron deficiency

300

2.07

6.77

2.3

1.9

27.42

37.07

u/l

0.42

275

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

126

2.70

6.74

2.3

1.4

44.89

41.00

u/l

0.05

113

Diseases of arteries, arterioles and capillaries

130

591

1.64

6.50

2.2

2.0

52.73

37.48

u/l

0.36

124

535

Concussion

425

1.81

6.48

1.7

2.1

30.14

42.86

u/l

0.38

381

Spondylopathies

152

580

1.59

6.46

1.7

2.0

43.47

38.26

u/l

0.12

139

518

Cholelithiasis, broad definition with cholecystitis

160

703

1.56

6.40

1.9

2.0

35.10

36.93

u/l

0.06

137

638

Dental pulpitis 4

198

685

1.50

6.31

1.9

22.01

42.02

u/l

2.60

182

619

Diseases of the digestive system

500

1.78

6.23

2.0

1.9

41.50

41.22

u/l

0.01

459

Disorders of thyroid, IBD co-morbidities

2.94

6.21

2.3

2.2

20.12

63.13

u/l

0.68

Dorsopathies

190

642

1.51

6.21

1.8

1.9

45.64

36.66

u/l

0.27

181

572

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

177

761

1.52

6.16

2.0

26.68

41.15

u/l

1.08

163

680

Noninfective enteritis and colitis

496

1.77

6.12

1.8

1.9

30.16

37.89

u/l

0.31

444

Non-ischemic cardiomyopathy

253

2.02

6.12

2.2

2.1

23.45

44.31

u/l

1.27

236

Dental pulpitis 1

197

686

1.49

6.11

1.9

22.00

41.99

u/l

2.59

181

620

Diseases of pulp and periapical tissues, including avohilmo

197

686

1.49

6.10

1.9

22.00

41.99

u/l

2.59

181

620

Obesity due to excess calories

461

1.80

6.09

1.5

1.9

21.28

32.28

u/l

0.73

412

Diseases of liver

369

1.90

6.06

1.8

1.9

57.71

35.75

u/l

0.42

339

Other specific joint derangements/joint disorders

124

509

1.63

6.00

1.9

45.79

40.37

u/l

0.10

103

462

Gingivitis and periodontal diseases

166

558

1.54

5.89

1.7

2.0

23.87

44.34

u/l

2.20

153

506

Antihypertensive medication - note that there are other indications

103

328

1.72

5.77

1.7

1.9

41.67

34.92

u/l

0.14

287

Use of hypnotics and sedatives

190

744

1.48

5.76

1.8

2.0

40.21

38.72

u/l

0.04

171

671

Soft tissue disorders

184

640

1.49

5.76

1.7

1.9

39.93

38.09

u/l

0.05

167

574

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

120

2.29

5.73

2.0

1.4

42.43

34.89

u/l

0.12

107

Other reaction to severe stress, and adjustment disorders

307

1.96

5.69

2.0

1.7

38.98

32.23

u/l

0.18

277

Other nutritional deficiencies

109

651

1.64

5.68

1.5

2.0

33.39

34.25

u/l

0.02

584

Disorders of the thyroid gland

170

745

1.49

5.56

2.1

1.9

27.40

40.41

u/l

1.04

149

672

Genitourinary diseases

118

360

1.65

5.53

1.9

1.8

49.44

30.72

u/l

0.52

107

330

General examination and investigation of persons without complaint and reported diagnosis

100

311

1.71

5.51

1.9

1.5

46.99

33.71

u/l

0.33

275

Pain in limb

133

615

1.57

5.50

2.0

1.9

53.88

38.96

u/l

0.33

118

550

Gout, idiopatic and unspecified

264

2.01

5.44

1.9

2.0

18.01

49.60

u/l

1.99

246

Chronic gastritis

280

1.97

5.32

1.7

1.9

68.59

33.14

u/l

0.59

256

Cholelithiasis

149

692

1.51

5.26

1.9

2.0

34.00

34.27

u/l

0.01

128

629

Asthma (diagnoses ohter than nonallergic)

150

858

1.50

5.22

1.6

2.0

16.89

41.17

u/l

4.64

135

773

Polyneuropathies and other disorders of the peripheral nervous system

221

2.09

5.22

2.2

2.0

14.50

44.02

u/l

1.78

203

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

110

688

1.59

5.20

1.7

2.0

51.99

34.08

u/l

0.36

100

626

Obesity related asthma

332

1.87

5.18

1.5

2.0

14.11

38.40

u/l

2.12

300

Low back pain

125

618

1.56

5.17

2.4

1.9

31.26

37.32

u/l

0.19

116

549

Other arrhythmias

109

519

1.61

5.15

1.8

1.9

44.02

33.55

u/l

0.24

465

Dysphagia

209

2.11

5.14

1.5

1.8

17.88

32.68

u/l

0.86

192

Other joint disorders

149

523

1.52

5.11

1.7

1.9

35.89

40.12

u/l

0.10

135

475

Disturbances of skin sensation

237

2.03

5.07

1.6

1.7

24.70

27.74

u/l

0.11

213

Cerebral palsy and other paralytic syndromes

104

2.60

5.04

1.9

1.7

31.94

64.27

u/l

0.63

Other disorders of teeth and supporting structures

211

2.09

5.03

2.2

2.1

18.78

46.80

u/l

1.27

192

Diseases of oral cavity, salivary glands and jaws

162

559

1.49

5.02

1.8

2.0

22.34

44.26

u/l

2.49

151

507

Diverticular disease of intestine

129

556

1.54

4.98

1.8

2.1

29.96

41.10

u/l

0.41

123

498

Herpesviral [herpes simplex] infections

100

2.61

4.88

1.7

1.9

56.52

47.23

u/l

0.10

Arthrosis

130

463

1.54

4.87

2.0

45.81

42.84

u/l

0.06

120

423

External causes of morbidity and mortality

125

401

1.56

4.83

1.6

2.2

51.28

29.72

u/l

0.55

112

359

Symptoms and signs involving cognition, perception, emotional state and behaviour

167

809

1.45

4.81

2.0

25.98

40.19

u/l

0.98

143

736

Disorders of sclera, cornea, iris and ciliary body

596

1.61

4.80

1.8

2.0

22.68

37.88

u/l

1.01

541

Dental caries 3

152

522

1.49

4.76

2.0

30.69

42.24

u/l

0.49

142

476

Biological medication for rheuma

132

2.35

4.72

1.3

1.8

17.33

44.89

u/l

1.16

121

Gout, unspecified

210

2.05

4.71

2.0

17.36

42.59

u/l

1.29

195

Gout, strict definition

190

2.11

4.71

1.9

2.1

20.05

45.69

u/l

1.14

178

Dental caries 3 and operation codes

163

572

1.46

4.68

2.0

21.90

44.51

u/l

2.63

152

521

Other diseases of upper respiratory tract

200

742

1.41

4.67

1.7

2.0

20.57

43.01

u/l

3.10

180

670

Diplopia

121

2.40

4.63

1.6

1.9

16.18

57.35

u/l

1.27

113

Codeine or tramadol medication

199

787

1.40

4.62

1.9

2.0

42.44

36.66

u/l

0.16

188

701

Symptoms and signs involving the urinary system

136

708

1.49

4.57

1.8

2.0

41.35

38.02

u/l

0.08

125

640

Acute tubulo-interstitial nephritis

102

575

1.57

4.56

1.6

2.0

46.43

28.20

u/l

0.50

521

Allergic asthma (mode), excluding more controls

126

2.34

4.51

1.3

1.8

15.98

22.79

u/l

0.32

110

Other and unspecified tonsillitis

238

1.89

4.51

2.1

1.7

38.56

47.03

u/l

0.15

213

Injury, poisoning and certain other consequences of external causes

101

314

1.61

4.48

1.7

2.2

57.50

32.14

u/l

0.52

279

STROKE

105

464

1.57

4.48

1.7

2.1

23.00

41.24

u/l

1.61

416

404

1.70

4.47

2.1

2.0

44.12

39.67

u/l

0.06

375

Conjunctivitis (acute, non atopic)

263

1.90

4.42

1.7

1.8

13.41

30.16

u/l

1.28

242

Other disorders of skin and subcutaneous tissue

119

724

1.51

4.41

2.3

2.0

33.60

37.34

u/l

0.14

113

655

Spondylosis

520

1.58

4.40

1.8

2.0

19.05

40.00

u/l

2.56

466

Dental pulpitis 2

128

433

1.51

4.38

2.1

1.9

33.64

45.85

u/l

0.41

118

400

Episodal and paroxysmal disorders

193

708

1.40

4.37

1.8

1.9

24.63

44.36

u/l

1.68

182

631

Lower back pain or/and sciatica

173

852

1.41

4.35

2.2

1.9

35.92

37.94

u/l

0.06

160

763

Allergic asthma (mode)

129

2.29

4.30

1.3

1.7

15.98

24.09

u/l

0.41

112

Dental pulpitis 4, only avohilmo

194

729

1.39

4.28

1.8

1.9

21.31

43.86

u/l

2.94

178

657

Obesity

632

1.55

4.26

1.5

1.9

36.09

34.27

u/l

0.04

566

Dental caries, including avohilmo

141

490

1.47

4.22

2.0

32.07

42.87

u/l

0.40

130

450

Obesity and other hyperalimentation

633

1.55

4.22

1.5

1.9

36.09

34.22

u/l

0.04

567

Dental caries 1

141

491

1.47

4.18

2.0

32.07

42.79

u/l

0.40

130

451

Malignant neoplasm of respiratory system and intrathoracic organs

221

1.92

4.17

2.2

2.0

18.01

45.12

u/l

1.43

204

Chronic sinusitis

442

1.65

4.08

1.8

2.0

15.44

40.43

u/l

2.52

397

Dental caries 1 and operation codes

153

547

1.44

4.05

2.0

21.58

44.87

u/l

2.56

143

501

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

117

2.05

4.01

2.1

1.4

47.19

35.31

u/l

0.17

105

Haemorrhage from respiratory passages

342

1.71

3.97

2.0

37.58

36.83

u/l

0.02

314

Other disorders of fluid, electrolyte and acid-base balance

278

1.81

3.96

2.2

1.8

19.20

46.19

u/l

1.76

257

Hypothyroidism, strict autoimmune

110

484

1.51

3.90

2.1

2.0

30.10

41.80

u/l

0.63

443

Benign neoplasm: Parotid gland

3.27

3.90

2.1

1.5

17.17

53.49

u/l

0.52

Subjective visual disturbances

233

1.89

3.90

1.8

2.1

16.89

41.81

u/l

1.38

213

Nerve, nerve root and plexus disorders

177

808

1.38

3.87

1.9

2.0

62.35

32.95

u/l

0.92

160

727

Dental pulpitis 1, only avohilmo

192

735

1.36

3.84

1.8

1.9

21.38

43.75

u/l

2.93

176

663

Seropositive rheumatoid arthritis, wide

271

1.81

3.80

1.7

2.0

48.71

35.24

u/l

0.16

244

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

12.49

3.80

1.5

1.8

11.20

33.16

u/l

—

Other diseases of intestine

120

2.26

3.79

1.7

2.1

30.61

36.81

u/l

0.13

104

Diseases of male genital organs

104

344

1.53

3.77

2.3

1.9

43.20

37.31

u/l

0.13

319

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

265

1.81

3.75

1.7

2.0

49.88

35.45

u/l

0.17

240

Other dorsopathies, not elsewhere classified

168

640

1.39

3.71

1.9

42.81

36.75

u/l

0.16

155

570

Dermatopolymyositis (FG)

6.75

3.68

2.3

1.2

35.80

89.03

u/l

—

Exclusions for E4_PCOS_CONSORTIUM

106

444

1.50

3.65

1.6

1.9

38.54

30.01

u/l

0.21

399

Other/unspecified seropositive rheumatoid arthritis

270

1.78

3.55

1.7

2.0

49.88

35.24

u/l

0.18

244

Spinal stenosis

456

1.53

3.55

2.0

2.1

61.76

38.00

u/l

0.41

412

Disorders of conjunctiva

128

756

1.42

3.52

1.7

1.9

51.81

34.27

u/l

0.39

115

681

Disorders of skin appendages

481

1.56

3.39

1.8

24.75

35.45

u/l

0.57

433

Neurotic, stress-related and somatoform disorders

141

723

1.39

3.35

1.8

1.9

42.37

35.95

u/l

0.19

124

650

Complications of internal orthopaedic prosthetic devices, implants and grafts

224

1.83

3.35

1.7

2.0

23.11

36.37

u/l

0.68

208

0.00

3.31

0.0

1.8

—

55.47

—

Anxiety disorders

142

729

1.38

3.30

1.8

1.9

42.37

36.12

u/l

0.19

125

657

Fall on same level

189

795

1.33

3.29

1.7

2.0

32.14

37.88

u/l

0.22

171

714

Migraine

357

1.60

3.28

1.5

1.8

15.25

35.14

u/l

1.58

313

Gonarthrosis

109

430

1.46

3.26

1.9

2.0

59.44

43.73

u/l

0.25

100

393

Asthma, including avohilmo

191

840

1.32

3.24

1.6

2.0

20.57

41.18

u/l

2.75

174

757

Sulfasalazine

220

1.82

3.21

2.0

1.9

51.69

24.17

u/l

0.33

200

Psoriasis

294

1.70

3.21

1.8

1.9

15.97

37.38

u/l

1.58

272

Other disorders of eye and adnexa

123

2.12

3.19

1.3

1.8

16.69

59.09

u/l

1.26

116

Other diseases of arteries and capillaries

2.36

3.15

2.2

1.8

93.91

48.44

u/l

0.25

Constipation

145

763

1.36

3.12

1.8

2.0

24.72

40.14

u/l

1.50

131

690

Statin medication

122

485

1.41

3.11

1.7

2.0

49.91

34.86

u/l

0.35

117

439

Anxiety disorders, excluding more controls

137

661

1.37

3.09

1.8

2.0

43.19

30.78

u/l

0.43

120

602

Melanocytic naevi, other sites/unspecified

3.08

3.09

1.8

1.6

12.22

60.64

u/l

0.64

Chronic lower respiratory diseases

195

806

1.31

3.07

1.8

2.0

28.23

39.75

u/l

0.83

176

725

Valvular operations

125

2.08

3.07

1.3

2.2

23.90

34.47

u/l

0.40

119

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

656

1.45

3.06

1.7

2.0

55.03

33.33

u/l

0.39

592

Dental pulpitis 2, only avohilmo

125

456

1.40

3.04

2.1

1.9

33.77

45.06

u/l

0.38

116

419

Type 2 diabetes, wide definition

137

652

1.37

3.03

2.1

2.0

34.79

38.49

u/l

0.11

123

592

Gonarthrosis [arthrosis of knee](FG)

115

479

1.41

3.00

1.9

2.1

56.87

43.14

u/l

0.23

105

437

Malignant neoplasm of skin

105

555

1.43

2.99

2.4

2.0

16.79

43.98

u/l

3.66

511

Dental operations

115

416

1.42

2.98

2.1

24.66

46.73

u/l

1.77

106

384

Other and unspecified urticaria

168

1.91

2.98

2.2

1.8

15.97

50.54

u/l

1.52

156

Benign neoplasm: Cerebral meninges

2.75

2.98

1.8

1.5

13.86

47.16

u/l

0.60

Epilepsy

331

1.63

2.96

1.6

1.8

30.82

43.05

u/l

0.45

295

Falls/tendency to fall

187

715

1.31

2.94

1.6

2.1

37.31

35.79

u/l

0.04

172

640

Hernia

152

773

1.33

2.88

1.9

2.0

27.94

38.69

u/l

0.52

139

698

Melanocytic naevi

282

1.67

2.84

1.8

1.9

23.78

36.98

u/l

0.41

257

Symptoms and signs involving the nervous and musculoskeletal systems

642

1.43

2.83

2.0

18.07

40.75

u/l

2.70

583

Cerebrovascular diseases

125

655

1.37

2.81

1.8

2.1

32.21

43.78

u/l

0.58

113

594

Diaphragmatic hernia

384

1.56

2.81

2.1

2.0

24.19

41.84

u/l

0.93

350

Other functional intestinal disorders

441

1.51

2.80

2.1

2.0

26.80

33.62

u/l

0.37

394

Coxarthrosis [arthrosis of hip](FG)

408

1.47

2.80

1.8

2.2

50.49

43.84

u/l

0.12

374

Hypothyreosis and Thyroxine purchase for inclusion criteria

147

727

1.34

2.79

2.0

1.9

29.68

36.74

u/l

0.44

129

656

Hard cardiovascular diseases

134

635

1.36

2.79

1.7

2.1

20.16

46.02

u/l

3.15

123

573

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

315

1.62

2.77

1.8

1.9

18.67

34.09

u/l

0.96

285

Conjunctivitis

109

687

1.38

2.71

1.7

1.9

35.13

34.48

u/l

0.01

617

Use of donepezil

191

0.35

2.66

2.4

1.9

10.11

48.96

u/l

—

179

Tumor necrosis factor alpha inhibitors

119

2.02

2.65

1.3

1.8

14.92

41.87

u/l

1.06

109

Hypothyroidism, other/unspecified

140

694

1.33

2.64

2.0

1.9

27.91

37.64

u/l

0.67

122

627

Benign neoplasm of meninges

2.55

2.61

1.8

1.5

13.86

48.23

u/l

0.68

Other disorders of urethra and urinary system

104

562

1.39

2.59

1.9

36.42

32.13

u/l

0.12

507

Dental caries 3, only avohilmo

143

549

1.33

2.59

1.9

2.0

31.81

41.32

u/l

0.37

134

499

Other disorders of veins

360

1.56

2.59

1.6

1.9

28.73

33.84

u/l

0.14

328

Acute myeloid leukaemia

5.53

2.55

1.0

1.5

100.50

23.83

u/l

—

Dental caries 1, only avohilmo

136

520

1.34

2.54

2.0

33.38

41.67

u/l

0.29

127

476

Insulin medication

603

1.39

2.53

2.0

37.41

39.23

u/l

0.04

547

Spondyloarthritis

164

1.83

2.52

1.6

1.8

12.70

53.50

u/l

1.86

152

Polycystic ovarian syndrome, consortium definition

402

1.41

2.50

1.8

48.55

30.48

u/l

0.38

355

Exposure to unspecified factor

149

890

1.30

2.45

1.5

2.0

32.40

38.11

u/l

0.19

128

809

Congenital malformations, deformations and chromosomal abnormalities

577

1.41

2.45

2.0

1.8

22.90

35.42

u/l

0.70

524

Papulosquamous disorders

439

1.48

2.43

1.9

20.73

39.67

u/l

1.47

401

Diseases of the ear and mastoid process

190

758

1.27

2.42

2.0

1.9

31.46

39.64

u/l

0.39

174

678

Other diseases of hard tissues of teeth

523

1.38

2.40

2.0

2.1

39.49

44.99

u/l

0.09

473

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

560

1.42

2.39

1.9

2.1

14.28

45.88

u/l

3.85

507

Malignant neoplasm of parotid gland, excluding all cancers (controls excluding all cancers)

6.32

2.38

3.0

1.4

25.60

25.85

u/l

—

Conductive and sensorineural hearing loss

134

706

1.32

2.37

1.9

2.0

28.83

42.48

u/l

0.63

124

637

Accidents

144

550

1.31

2.37

1.6

2.1

29.83

40.00

u/l

0.38

131

495

Other external causes of accidental injury

144

550

1.31

2.37

1.6

2.1

29.45

40.00

u/l

0.40

132

495

Disorders of lens

116

544

1.35

2.36

1.9

2.1

50.53

42.12

u/l

0.17

104

496

Excessive, frequent and irregular menstruation

205

1.55

2.36

1.8

1.7

59.09

28.58

u/l

0.41

183

Other disorders of ear

151

778

1.29

2.36

2.0

25.63

40.57

u/l

0.86

140

701

Cystitis

128

593

1.32

2.29

2.0

1.9

45.80

33.76

u/l

0.37

114

535

Dental operations, only avohilmo

121

464

1.34

2.28

2.0

2.1

24.81

44.23

u/l

1.65

112

423

Injuries to the wrist and hand

151

853

1.28

2.27

1.9

47.60

35.61

u/l

0.35

139

764

Disorders of choroid and retina

131

730

1.31

2.26

2.1

2.0

28.47

43.56

u/l

1.08

123

658

Insulin, combination of fast acting with intermediate-acting or long-acting

666

1.36

2.25

2.0

37.41

40.54

u/l

0.06

605

Sciatica+with lumbago

511

1.41

2.23

2.0

1.9

54.80

38.82

u/l

0.27

455

Arterial embolism and thrombosis

2.34

2.21

2.4

1.5

67.59

66.33

u/l

0.01

Ocular pain

2.20

2.21

1.4

1.9

21.46

56.51

u/l

0.70

Other respiratory disorders and diseases

211

1.66

2.15

2.0

37.11

45.82

u/l

0.23

192

Other diseases of the respiratory system

211

1.66

2.15

2.0

37.11

45.82

u/l

0.23

192

Other diseases of urinary system

161

714

1.27

2.14

1.9

43.68

35.68

u/l

0.25

144

642

Other intervertebral disc disorders

128

601

1.30

2.13

1.7

2.0

17.46

37.59

u/l

3.10

116

536

Presence of other functional implants

479

1.36

2.09

2.2

2.0

63.08

42.44

u/l

0.31

442

Cholecystectomy

108

724

1.32

2.07

2.0

31.77

35.77

u/l

0.10

657

Other headache syndromes

422

1.45

2.07

1.8

1.9

37.65

42.85

u/l

0.10

371

Insulin, intermediate and long-acting

629

1.36

2.05

2.0

38.69

42.17

u/l

0.06

571

Benign neoplasm of bone and articular cartilage

2.50

2.01

2.0

1.5

29.26

52.71

u/l

0.28

Hypothyroidism, strict autoimmune, 3 medication purchases required

124

655

1.29

1.98

2.0

1.8

33.90

36.44

u/l

0.10

109

588

Leiomyoma of uterus

338

1.38

1.98

1.7

1.9

26.54

38.16

u/l

0.47

301

Colectomy operation

178

1.69

1.98

2.0

74.87

40.27

u/l

0.26

163

Dizziness and giddiness

116

726

1.30

1.97

2.1

1.9

36.41

39.98

u/l

0.12

102

662

Shoulder lesions

121

573

1.29

1.93

2.1

1.9

44.18

40.29

u/l

0.08

108

515

Focal epilepsy

218

1.61

1.92

1.5

2.0

33.72

43.44

u/l

0.27

199

Temporomandibular joint disorders, including avohilmo

362

1.46

1.92

1.4

1.8

12.38

32.61

u/l

2.06

324

Hyperplasia of prostate

284

1.41

1.90

2.9

2.0

55.07

39.87

u/l

0.26

263

Coxarthrosis

380

1.38

1.89

1.6

2.1

53.36

44.61

u/l

0.15

347

Keratitis

356

1.46

1.89

1.7

1.9

29.37

41.59

u/l

0.37

327

Disorders of vitreous body

529

1.37

1.87

1.6

2.1

17.09

43.50

u/l

3.16

484

Stroke, excluding SAH

546

1.32

1.87

1.9

2.1

22.23

42.79

u/l

1.98

502

Coxibs

173

1.51

1.86

2.2

1.8

31.49

33.49

u/l

0.05

157

Other general symptoms and signs

3.15

1.85

1.3

2.9

9.70

41.41

u/l

—

Demyelinating diseases of the central nervous system

2.03

1.85

1.3

1.9

9.29

49.19

u/l

1.14

Neuromuscular dysfunction of bladder

2.03

1.85

1.1

1.9

16.11

44.56

u/l

0.62

Stroke, including SAH

101

571

1.31

1.84

1.8

2.1

24.01

45.35

u/l

1.87

523

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

2.21

1.84

2.0

1.4

15.82

41.97

u/l

0.51

Menorrhagia

190

1.49

1.83

1.7

64.05

29.13

u/l

0.42

171

Disorders of vitreous body and globe

547

1.36

1.81

1.6

2.1

16.93

43.39

u/l

3.34

502

Other arthrosis

417

1.36

1.81

1.6

2.0

34.55

43.99

u/l

0.18

381

Sensorineural hearing loss

122

672

1.27

1.77

1.8

2.0

30.86

42.56

u/l

0.47

113

606

Coronary atherosclerosis

113

567

1.29

1.77

1.8

2.1

42.30

42.67

u/l

0.01

104

515

Other cataract

408

1.37

1.76

1.6

2.1

16.67

43.53

u/l

2.49

375

Senile cataract

105

502

1.30

1.75

2.0

2.1

54.84

44.31

u/l

0.20

458

Ischaemic heart disease, wide definition

125

617

1.27

1.75

1.9

2.1

47.79

41.83

u/l

0.11

115

561

Ischaemic Stroke, excluding all haemorrhages

516

1.32

1.75

1.9

2.1

23.45

44.06

u/l

1.81

477

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

2.23

1.73

2.0

1.4

13.38

45.19

u/l

0.58

Sleep disorders (combined)

153

812

1.24

1.73

1.8

1.9

28.35

40.35

u/l

0.56

141

728

Calcific aortic valvular stenosis

307

1.47

1.72

1.9

2.0

63.18

40.19

u/l

0.27

284

Calcific aortic valvular stenosis, operated

307

1.47

1.72

1.9

2.0

63.18

40.19

u/l

0.27

284

Operations 2 for CAVS

307

1.47

1.72

1.9

2.0

63.18

40.19

u/l

0.27

284

Calcific aortic valvular stenosis, diagnosis (helper)

307

1.47

1.72

1.9

2.0

63.18

40.19

u/l

0.27

284

Glucagon-like peptide-1 (GLP-1) analogues

564

1.31

1.72

2.1

38.41

43.84

u/l

0.12

514

Calcific aortic valvular stenosis, including rheumatic fever

307

1.47

1.72

1.9

2.0

63.18

40.19

u/l

0.27

284

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

2.13

1.71

1.5

1.4

17.63

41.45

u/l

0.47

Conduction disorders

233

1.50

1.71

2.3

2.2

74.20

33.37

u/l

0.54

215

Type of accident

274

1.50

1.70

2.6

1.9

35.37

38.49

u/l

0.05

251

Injuries to the hip and thigh

472

1.36

1.70

1.6

2.0

21.69

36.63

u/l

1.31

437

Artrosis, including avohilmo

136

596

1.25

1.69

1.9

48.06

40.51

u/l

0.17

127

532

Disorders of breast

400

1.39

1.68

2.3

1.8

44.17

32.81

u/l

0.14

356

Injuries to the head

164

876

1.22

1.66

1.8

2.0

42.17

36.34

u/l

0.16

150

788

Lung diseases due to external agents

134

1.72

1.65

2.0

23.25

45.33

u/l

0.77

123

Iron deficiency anaemia secondary to blood loss (chronic)

150

1.67

1.62

2.4

1.9

33.64

55.12

u/l

0.50

139

Continuous positive airway pressure

162

1.60

1.62

1.5

2.2

28.86

33.74

u/l

0.14

148

Triptan medication for migraine, single purchase ok

105

556

1.28

1.62

1.7

1.8

19.38

33.11

u/l

1.07

496

Migraine, single triptan purchase ok & required. ICD-code if available is included

105

556

1.28

1.62

1.7

1.8

19.38

33.11

u/l

1.07

496

Angina pectoris

100

525

1.29

1.62

1.9

2.1

54.86

41.74

u/l

0.22

479

Benign neoplasm of colon, rectum, anus and anal canal

666

1.29

1.61

2.0

2.1

48.04

39.62

u/l

0.16

605

Asthma, hospital admissions , main diagnosis only

120

860

1.25

1.60

1.5

2.0

17.49

39.57

u/l

3.91

107

776

Seropositive rheumatoid arthritis, strict definition

151

1.66

1.59

1.6

1.8

88.35

42.45

u/l

0.30

141

Squamous cell neoplasms and carcinomas of the skin

129

1.71

1.56

2.1

2.0

12.70

59.87

u/l

1.73

120

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

322

1.43

1.54

1.4

1.9

16.96

37.92

u/l

1.52

297

Viral and other specified intestinal infections

149

1.64

1.53

1.7

14.06

57.37

u/l

1.66

137

Benign neoplasm: Colon

601

1.30

1.52

2.0

2.1

53.25

37.20

u/l

0.28

553

Irregular menses

308

1.40

1.52

1.7

23.73

29.95

u/l

0.29

269

Benign neoplasm of eye and adnexa

2.16

1.50

1.8

1.5

32.36

46.89

u/l

0.18

Inflammatory diseases of female pelvic organs

422

1.32

1.50

1.8

26.49

34.85

u/l

0.36

373

Cholecystitis

131

1.68

1.49

2.0

2.1

39.34

52.30

u/l

0.28

120

Other and unspecified disorders of vitreous body

441

1.35

1.48

1.7

2.1

17.61

38.29

u/l

2.12

403

Dermatophytosis

124

1.70

1.46

1.4

1.9

15.83

56.87

u/l

1.35

117

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

276

1.45

1.46

1.7

1.8

90.04

38.85

u/l

0.43

249

Ovarian cyst

200

1.42

1.46

1.8

1.7

14.32

28.70

u/l

1.07

179

Diseases of middle ear and mastoid

477

1.31

1.44

2.5

1.7

38.47

30.94

u/l

0.25

429

Triptan medication for migraine, min. 3 purchases

391

1.33

1.43

1.9

1.6

10.43

34.03

u/l

2.87

345

Schizophrenia

151

0.46

1.43

2.0

1.9

22.73

28.53

u/l

—

141

Nontoxic diffuse goitre

2.42

1.39

3.3

1.7

8.61

94.53

u/l

—

Melanoma in situ of trunk

2.96

1.36

1.2

2.1

10.02

20.88

u/l

—

Other bursopathies

127

1.66

1.36

1.9

2.0

12.14

32.45

u/l

1.32

119

Special screening examination for infectious and parasitic diseases

117

1.60

1.36

1.6

1.3

26.66

29.75

u/l

0.07

103

Disorders of ocular muscles, binocular movement, accommodation and refraction

464

1.33

1.36

1.4

1.8

30.99

31.11

u/l

0.00

423

Ischemic heart diseases

122

623

1.23

1.35

1.9

2.1

49.08

41.46

u/l

0.14

112

566

Mood disorders, excluding more controls

145

732

1.21

1.35

1.8

2.0

39.37

32.34

u/l

0.24

129

667

Disorders of synovium and tendon

525

1.29

1.32

2.1

1.9

63.81

38.67

u/l

0.34

468

Mood disorders

151

833

1.19

1.27

1.7

2.0

38.74

37.42

u/l

0.04

134

751

Other specified/unspecified hearing loss

1.79

1.27

2.3

2.0

17.49

75.02

u/l

1.25

Benign lipomatous neoplasm

302

1.39

1.26

1.9

2.0

28.68

35.92

u/l

0.24

278

Nonsuppurative otitis media

167

1.50

1.26

2.9

1.6

22.43

46.94

u/l

0.89

156

Other malignant neoplasms of skin (=non-melanoma skin cancer)

505

1.27

1.25

2.4

2.0

16.92

43.86

u/l

3.22

462

Depression or dysthymia

111

506

1.23

1.24

1.8

2.1

26.16

35.14

u/l

0.53

101

464

All anxiety disorders

487

1.27

1.24

1.8

1.7

48.32

30.89

u/l

0.37

438

Other degenerative diseases of the nervous system

209

1.42

1.24

2.0

2.2

13.42

42.25

u/l

3.17

192

Dementia

342

0.71

1.23

2.3

2.0

14.67

44.24

u/l

2.93

321

Mood [affective] disorders

150

831

1.19

1.23

1.7

2.0

38.95

37.46

u/l

0.04

133

750

Depression

137

790

1.19

1.21

1.7

1.9

40.81

36.78

u/l

0.11

120

712

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

131

1.49

1.20

1.5

1.4

19.44

30.22

u/l

0.38

113

Dementia, including avohilmo

363

0.72

1.19

2.4

2.0

18.67

44.94

u/l

2.19

340

Presence of cardiac and vascular implants and grafts

408

1.28

1.17

2.2

2.1

21.03

44.90

u/l

2.08

377

Other neurological diseases

106

702

1.21

1.15

2.1

2.0

20.28

39.84

u/l

2.49

636

Intracranial injury

628

1.25

1.15

1.6

2.0

27.25

35.80

u/l

0.32

568

Behavioural syndromes associated with physiological disturbances and physical factors

283

1.38

1.13

1.7

52.08

31.92

u/l

0.22

258

Psychiatric diseases

170

729

1.17

1.12

1.9

2.0

50.73

32.37

u/l

0.51

148

666

Acute and transient psychotic disorders

112

0.45

1.12

2.4

1.9

12.18

46.64

u/l

—

105

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

2.34

1.12

1.3

1.4

43.61

76.32

u/l

—

Parodontitis

132

821

1.19

1.11

1.7

2.0

55.08

36.10

u/l

0.42

114

747

Diabetes mellitus

150

762

1.17

1.10

1.8

2.0

41.06

35.80

u/l

0.13

132

688

Parodontitis or operation codes

132

821

1.18

1.10

1.7

2.0

55.08

36.10

u/l

0.42

114

747

Supplementary factors related to causes of morbidity and mortality classified elsewhere

303

1.35

1.08

2.6

1.9

35.38

36.30

u/l

0.01

279

Cervical disc disorders

399

1.30

1.07

1.8

2.1

24.26

41.95

u/l

1.00

357

Meniscus derangement

441

1.24

1.07

2.1

2.0

48.67

42.74

u/l

0.09

404

Postpartum care and examination

0.45

1.04

1.4

1.2

27.74

38.83

u/l

—

Use of levodopa decarboxylase inhibitor

148

0.54

1.03

1.9

2.0

15.04

55.24

u/l

—

137

Basal cell carcinoma

533

1.23

1.01

2.2

2.0

20.23

45.41

u/l

2.54

487

Respiratory insufficiency

1.89

1.00

2.0

2.1

24.70

39.23

u/l

—

Excessive attrition of teeth

207

1.31

0.99

1.9

2.0

64.51

31.98

u/l

0.35

181

Primary gonarthrosis, bilateral

532

1.23

0.99

1.8

2.1

18.16

35.87

u/l

2.50

487

Inguinal hernia

512

1.21

0.99

2.0

46.08

45.63

u/l

0.01

469

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

334

1.32

0.98

1.6

54.52

38.89

u/l

0.15

303

Chronic periodontitis, including avohilmo

130

823

1.17

0.96

1.7

2.0

55.15

36.14

u/l

0.41

112

749

Diabetes, varying definitions

148

763

1.16

0.96

1.8

2.0

41.53

35.72

u/l

0.14

130

690

Anxiety (asthma-related co-morbidities)

496

1.22

0.95

1.8

48.32

28.08

u/l

0.45

445

Fracture of femur

236

1.35

0.94

1.6

2.1

18.13

46.76

u/l

1.78

219

Other obstetric conditions, not elsewhere classified

139

1.40

0.94

1.5

1.4

19.44

28.85

u/l

0.35

121

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

1.59

0.94

1.1

1.4

15.77

37.55

u/l

0.74

Other symptoms and signs involving the nervous and musculoskeletal systems

427

1.27

0.92

2.0

1.9

21.83

32.04

u/l

0.58

386

Emphysema

1.67

0.91

2.8

1.8

39.88

55.55

u/l

0.26

Abnormal serum enzyme levels

344

1.29

0.90

2.2

2.1

95.17

38.60

u/l

0.60

318

Disorders of refraction and accommodation

235

1.36

0.89

1.3

1.8

30.20

36.67

u/l

0.16

217

Carcinoma in situ of skin

1.86

0.87

1.6

1.5

43.93

54.39

u/l

—

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

1.86

0.87

1.0

1.5

30.35

53.74

u/l

—

Maternal care for other conditions predominantly related to pregnancy

142

1.46

0.87

1.3

1.5

19.26

37.36

u/l

0.60

123

Sleep apnoea

135

794

1.15

0.86

2.0

20.43

42.47

u/l

3.01

126

713

Unspecified/other endometriosis

1.67

0.85

1.5

19.53

40.11

u/l

—

Basal cell carcinoma, including avohilmo

539

1.20

0.84

2.2

2.0

20.23

45.02

u/l

2.51

493

Diabetes, insulin treatment (Kela reimbursement)

147

786

1.14

0.83

1.9

2.0

30.00

38.39

u/l

0.30

132

708

Delirium, not induced by alcohol and other psychoactive substances

111

0.54

0.83

1.5

1.8

44.73

64.61

u/l

—

103

Complications of labour and delivery

350

0.80

0.82

1.8

1.7

42.26

35.38

u/l

0.11

310

Sleep apnoea, including avohilmo

142

807

1.14

0.80

1.9

2.0

20.24

42.07

u/l

3.05

132

724

Maternal care for known or suspected malpresentation of fetus

0.57

0.79

1.6

1.3

10.50

32.39

u/l

—

Injuries to the shoulder and upper arm

118

858

1.15

0.79

1.7

2.0

41.46

38.08

u/l

0.08

106

780

Somatoform disorder

139

1.44

0.79

1.7

1.8

22.99

45.31

u/l

0.70

132

Artificial joint operation, meniscal resection

133

773

1.14

0.78

1.7

2.1

48.53

38.49

u/l

0.21

121

704

Glaucoma, exfoliation

124

0.56

0.77

2.6

2.0

9.86

61.26

u/l

—

116

Adjustment and management of implanted device

148

1.42

0.77

2.3

1.9

20.06

24.90

u/l

0.23

137

Other antidepressants

154

709

1.13

0.76

1.9

2.0

31.70

38.84

u/l

0.26

141

646

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

139

746

1.14

0.75

1.9

2.0

30.25

36.22

u/l

0.19

125

675

Gonarthrosis, primary, with knee surgery

561

1.18

0.73

1.8

2.1

59.71

35.52

u/l

0.37

514

Haemangioma, any site

1.75

0.71

1.1

1.5

11.71

59.05

u/l

—

D07AA Corticosteroids, weak (group I)

143

0.63

0.69

1.1

1.7

11.38

41.76

u/l

—

132

Parkinson's disease

169

0.65

0.68

2.7

2.0

13.57

50.28

u/l

1.70

155

Any mental disorder

167

749

1.12

0.67

1.8

2.0

53.98

32.15

u/l

0.61

145

684

Cervicalgia

196

1.33

0.67

2.0

1.9

78.02

24.99

u/l

0.39

176

Haemangioma and lymphangioma, any site

1.63

0.66

1.1

1.5

11.71

55.18

u/l

—

Non-selective monoamine reuptake inhibitors

425

1.21

0.66

1.9

2.0

66.63

35.89

u/l

0.45

390

Other hammer toe(s) (acquired)

144

1.37

0.65

2.6

2.0

14.18

41.15

u/l

1.78

136

Vascular disorders of the intestines

1.57

0.65

1.1

2.1

26.91

38.67

u/l

0.22

Other retinal disorders

619

1.16

0.65

2.0

30.31

41.98

u/l

0.58

563

Allergic conjunctivitis

541

1.18

0.64

1.7

1.8

49.73

30.29

u/l

0.36

484

Benign mammary dysplasia

120

1.42

0.64

2.8

1.8

10.46

47.05

u/l

1.69

112

Parkinson's disease, strict definition

153

0.65

0.62

2.9

2.0

14.53

54.18

u/l

—

140

Injury of eye and orbit

138

1.38

0.62

1.9

15.68

37.87

u/l

0.99

127

Parodontitis and operation codes

120

828

1.13

0.62

1.7

2.0

54.16

36.63

u/l

0.34

103

754

Other benign neoplasms of connective and other soft tissue

1.57

0.60

3.3

1.5

13.95

48.25

u/l

—

Acute appendicitis

760

1.14

0.60

2.2

1.9

18.15

40.22

u/l

3.03

682

Fistulae involving female genital tract

0.00

0.59

0.0

1.7

—

92.76

—

Dementia due to Parkinson's disease

0.00

0.59

0.0

1.5

—

22.77

—

Recurrent or chronic depression

307

1.20

0.59

1.9

1.8

30.22

30.02

u/l

0.00

282

FESS (DNB20)

114

1.40

0.58

2.1

2.0

16.31

59.45

u/l

1.24

106

Pre-eclampsia or poor fetal growth

242

0.74

0.58

1.9

1.5

9.62

41.30

u/l

2.10

207

Type 2 diabetes

139

741

1.11

0.58

1.9

2.0

31.00

36.36

u/l

0.18

123

668

Corneal ulcer

175

1.32

0.58

2.0

1.8

37.39

47.25

u/l

0.12

162

Suppurative and unspecified otitis media

282

1.23

0.57

2.2

1.6

37.14

37.08

u/l

0.00

260

Transient ischemic attack

508

1.16

0.56

1.9

2.1

22.34

44.93

u/l

1.96

470

Major coronary heart disease event

106

627

1.13

0.56

1.7

2.1

29.92

45.95

u/l

0.88

570

Gonarthrosis,primary

129

728

1.11

0.56

1.9

2.0

58.84

37.27

u/l

0.46

119

661

Urolithiasis

384

1.20

0.55

2.6

1.9

9.42

46.78

u/l

3.98

347

Diseases of appendix

791

1.13

0.55

2.1

1.9

17.63

39.29

u/l

3.18

712

Injuries to the ankle and foot

688

1.14

0.55

1.7

1.9

35.38

33.59

u/l

0.03

619

Appendicitis, broad definition

787

1.13

0.53

2.1

1.9

17.74

39.45

u/l

3.16

708

Type 2 diabetes, definitions combined, including avohilmo

135

721

1.11

0.53

1.9

2.0

32.07

39.20

u/l

0.24

119

650

Dislocation, sprain and strain of joints and ligaments of knee

636

0.86

0.52

1.6

2.0

15.05

38.92

u/l

3.32

571

Medical abortion

345

1.15

0.51

1.5

1.8

58.52

31.15

u/l

0.37

309

Alcohol use disorder, ICD-based

499

0.84

0.50

1.8

2.0

105.77

39.50

u/l

0.51

453

Asthma/COPD (KELA code 203)

126

803

1.11

0.50

1.6

2.0

23.08

39.87

u/l

1.80

113

722

Alcohol use disorder, Swedish definition

631

0.87

0.48

1.8

1.9

92.25

38.79

u/l

0.59

571

Carcinoma in situ of breast, intraductal

1.49

0.47

1.4

1.6

20.69

49.20

u/l

—

Benzodiazepine use

136

882

1.10

0.47

1.9

2.0

32.34

38.42

u/l

0.20

125

792

Type 2 diabetes, definitions combined

133

722

1.10

0.47

2.0

31.96

36.85

u/l

0.16

118

652

Mental and behavioural disorders due to alcohol

606

0.87

0.46

1.8

2.0

124.08

32.27

u/l

0.86

552

Glucosamine medication

469

1.14

0.46

1.7

2.0

39.33

43.28

u/l

0.07

429

Mental and behavioural disorders due to alcohol, excluding acute intoxication

536

0.86

0.45

1.7

2.0

101.76

39.42

u/l

0.52

489

Malignant neoplasm of bladder

0.61

0.45

3.2

1.9

18.82

45.03

u/l

—

Organic, including symptomatic, mental disorders

419

0.86

0.45

2.1

17.36

42.42

u/l

2.54

392

Hallux rigidus

120

0.67

0.45

2.0

2.1

14.25

38.81

u/l

—

109

Ectopic pregnancy

153

0.72

0.45

3.1

1.6

10.66

32.25

u/l

1.84

136

Diseases of peritoneum

103

1.36

0.45

2.4

1.8

34.89

65.27

u/l

0.45

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

1.40

0.45

2.4

1.6

29.60

70.24

u/l

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

219

1.23

0.44

1.2

1.6

125.70

29.44

u/l

0.55

202

Coronary revascularization (ANGIO or CABG)

418

1.14

0.43

1.6

2.1

25.72

43.88

u/l

0.98

387

malignant neoplasm of female genital organs

129

0.70

0.43

1.2

2.0

13.07

58.13

u/l

—

120

Type 2 diabetes, strict (exclude DM1)

133

728

1.09

0.42

2.0

31.96

38.90

u/l

0.23

118

657

Macular pucker

158

1.27

0.41

1.3

2.0

16.97

52.89

u/l

1.43

143

Carcinoma in situ of skin of ear and external auricular canal

0.00

0.41

0.0

1.6

—

20.69

—

675

0.89

0.41

1.8

1.9

111.15

34.97

u/l

0.90

609

Vascular dementia (mixed)

0.00

0.40

0.0

1.5

—

24.14

—

Occlusion and stenosis of arteries, not leading to stroke

0.00

0.40

0.0

1.7

—

14.38

—

Unspecified fall

546

0.87

0.40

1.4

1.9

58.46

37.09

u/l

0.27

499

Dental caries 2 and operation codes, only avohilmo

533

0.90

0.40

1.6

1.9

14.76

33.13

u/l

2.20

476

Wet age-related macular degeneration

179

0.77

0.39

3.3

1.9

64.07

52.55

u/l

0.12

166

Diabetes medication

140

785

1.08

0.39

1.8

2.0

42.05

35.46

u/l

0.16

124

709

Parkinson's disease, including avohilmo

171

0.76

0.39

2.5

2.1

19.53

49.51

u/l

1.22

157

Benign neoplasm of meninges

106

1.32

0.39

1.8

13.86

67.26

u/l

1.52

100

Malignant neoplasm of colon

160

1.25

0.38

2.0

19.01

51.99

u/l

1.32

148

657

0.89

0.37

1.7

2.0

108.59

36.31

u/l

0.78

594

Other disorders of eyelid

470

1.13

0.36

1.7

2.0

17.40

43.47

u/l

2.82

427

Maternal care for other known or suspected fetal problems

116

0.77

0.36

1.4

1.3

24.06

29.22

u/l

0.12

100

Other symptoms and signs involving cognitive functions and awareness

466

1.13

0.36

1.7

1.9

15.26

42.02

u/l

2.93

431

Pre-eclampsia

168

0.77

0.35

1.8

1.5

10.93

48.83

u/l

1.64

147

Poor fetal growth

0.63

0.35

1.8

1.5

5.70

53.00

u/l

—

Endometriosis ASRM stages 3,4

212

0.80

0.35

1.6

1.7

59.50

40.59

u/l

0.17

188

Other appendicitis

0.62

0.35

1.0

1.8

11.00

49.61

u/l

—

Other mental disorders due to brain damage and dysfunction and to physical disease

123

0.73

0.35

2.7

1.9

6.78

59.23

u/l

—

115

Disorders of psychological development

0.68

0.33

1.8

1.6

9.12

33.37

u/l

—

Malignant neoplasm of prostate

342

0.89

0.32

2.0

2.2

46.14

44.88

u/l

0.02

313

Gestational diabetes (for exclusion)

187

0.83

0.32

1.6

1.4

22.25

31.37

u/l

0.29

163

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

504

1.11

0.31

1.7

1.9

54.18

31.68

u/l

0.37

452

Abdominal aortic aneurysm (AAA)

110

1.26

0.30

4.1

2.0

24.56

27.80

u/l

0.14

Gastro-oesophageal reflux disease

693

1.09

0.29

2.2

2.0

17.46

41.90

u/l

3.42

622

Burns and corrosions

130

0.77

0.29

2.6

1.9

13.19

36.03

u/l

—

120

Emergency coronary revascularization (for ACS)

500

1.09

0.29

1.8

2.1

24.93

47.08

u/l

1.38

464

Polyp of the female genital tract

183

1.14

0.29

1.7

23.75

29.62

u/l

0.19

166

Anomalies of dental arch relationship, including avohilmo

146

0.80

0.28

1.1

1.8

164.05

49.19

u/l

0.35

135

Coxarthrosis, primary

639

1.09

0.28

1.8

2.1

53.57

37.40

u/l

0.33

585

Substance abuse

670

0.91

0.28

1.7

1.9

116.46

34.34

u/l

0.99

603

Noninflammatory disorders of female genital tract

206

1.12

0.28

1.7

101.34

28.65

u/l

0.78

184

Mental and behavioural disorders due to psychoactive substance use

680

0.92

0.27

1.7

1.9

142.13

31.24

u/l

1.31

612

Pre-eclampsia or eclampsia

183

0.82

0.27

1.9

1.5

10.53

47.69

u/l

1.76

157

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

469

0.90

0.27

1.6

1.9

43.39

31.17

u/l

0.25

417

Parkinson's disease, excluding more controls

135

0.79

0.26

2.7

2.4

13.57

46.80

u/l

2.26

123

Heterophoria

1.25

0.25

1.7

2.0

11.24

48.44

u/l

—

Diseases of inner ear

619

0.92

0.24

1.9

2.0

25.02

38.69

u/l

0.63

561

Injury of muscle and tendon at hip and thigh level

1.27

0.24

2.2

1.8

25.85

44.98

u/l

0.42

Dental caries 2, only avohilmo

670

0.93

0.24

1.6

1.9

14.68

34.40

u/l

2.72

606

Acute appendicitis, no complications

617

1.08

0.24

2.2

1.8

19.72

43.78

u/l

2.48

551

Appendectomy

698

1.08

0.24

2.1

1.9

18.19

37.64

u/l

2.69

626

Rotator cuff syndrome

539

1.07

0.23

2.0

39.52

40.79

u/l

0.02

484

Arthropod-borne viral fevers and viral haemorrhagic fevers

1.24

0.23

1.3

2.0

27.89

46.97

u/l

0.46

Deep bite

0.75

0.22

1.0

1.8

279.40

48.20

u/l

—

Open wound of forearm

0.75

0.22

1.0

1.8

14.13

49.79

u/l

—

Injuries to the knee and lower leg

160

873

1.05

0.22

1.5

2.0

32.76

38.03

u/l

0.19

138

793

Thiamine deficiency

0.00

0.21

0.0

2.0

—

25.05

—

Toxic effect of other gases, fumes and vapours

0.00

0.21

0.0

1.7

—

17.08

—

Benign neoplasm: Brain, unspecified

0.00

0.21

0.0

1.5

—

25.77

—

Carcinoma in situ of breast, lobular

0.00

0.21

0.0

1.3

—

142.96

—

Injury of blood vessels at wrist and hand level

0.00

0.21

0.0

1.5

—

9.68

—

Pedal cyclist injured in collision with pedestrian or animal

0.00

0.21

0.0

1.6

—

21.06

—

Other corneal oedema

0.00

0.21

0.0

1.4

—

27.76

—

Cicatricial alopecia [scarring hair loss]

0.00

0.21

0.0

1.6

—

22.65

—

Benign neoplasm: Pharynx, unspecified

0.00

0.21

0.0

1.5

—

13.21

—

Endometriosis of fallopian tube

0.00

0.21

0.0

2.3

—

145.67

—

Endometroid carcinoma of ovary

0.00

0.21

0.0

1.3

—

27.05

—

Benign neoplasm: Rectum/anal canal icd-9

0.00

0.21

0.0

1.5

—

27.98

—

Assault by other specified means

0.00

0.21

0.0

1.3

—

25.67

—

Other bursitis, not elsewhere classified

0.00

0.21

0.0

1.6

—

12.04

—

0.00

0.21

0.0

1.4

—

13.03

—

Other congenital malformations of nervous system

0.00

0.21

0.0

1.4

—

26.22

—

Tic disorders

0.00

0.21

0.0

1.4

—

27.75

—

Tic and related disorders

0.00

0.21

0.0

1.3

—

28.66

—

Endometriosis of intestine

0.00

0.21

0.0

2.3

—

137.64

—

Complications associated with artificial fertilization

0.00

0.21

0.0

2.2

—

19.04

—

Discontinuity and dislocation of ear ossicles

0.00

0.21

0.0

1.5

—

24.09

—

Fibrosarcoma

0.00

0.21

0.0

1.5

—

24.09

—

Kela-code for behavioural disturbances in mental retardation

0.00

0.21

0.0

1.5

—

22.96

—

Family history of other specific disorders

0.00

0.21

0.0

1.4

—

101.25

—

Other and unspecified mental retardation

0.00

0.21

0.0

1.4

—

24.67

—

Open wound of ankle and foot

102

0.78

0.21

1.3

1.8

45.75

47.01

u/l

—

Other (not insulin) diabetes medications

131

750

1.05

0.21

1.9

2.0

37.39

36.37

u/l

0.03

115

676

Unspecified threat to breathing

0.00

0.21

0.0

1.6

—

24.92

—

Secondary malignant neoplasm of respiratory and digestive organs

0.00

0.21

0.0

1.6

—

22.32

—

Alzheimer’s disease (undefined)

0.00

0.21

0.0

1.5

—

29.47

—

Parkinson's disease, strict definition, excluding more controls

121

0.81

0.20

2.9

2.4

14.53

43.84

u/l

—

111

Varicose veins

538

1.07

0.19

1.9

22.33

41.84

u/l

1.66

489

Focal brain injury

1.18

0.19

2.0

1.8

65.62

36.72

u/l

—

Coxarthrosis, primary, with hip surgery

520

1.08

0.19

1.7

2.1

33.43

38.68

u/l

0.23

479

Complications predominantly related to the puerperium

203

1.13

0.19

2.0

1.6

19.13

41.19

u/l

0.80

175

Fracture of lower leg, including ankle

649

0.94

0.18

1.3

2.0

61.79

38.23

u/l

0.39

590

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

1.15

0.17

1.6

11.24

59.38

u/l

—

Lumbar disc prolapse

585

1.06

0.17

1.8

2.0

16.93

37.95

u/l

3.04

522

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

1.11

0.17

1.6

1.7

11.24

68.68

u/l

—

Persons encountering health services in circumstances related to reproduction

400

1.07

0.17

2.0

1.7

15.10

39.31

u/l

2.38

365

Palmar fascial fibromatosis [Dupuytren]

173

0.87

0.16

1.7

2.0

18.37

29.88

u/l

0.54

160

Monoamine oxidase A inhibitors

120

0.83

0.16

1.2

2.0

15.58

49.79

u/l

—

111

Alzheimer’s disease (Atypical or mixed), excluding more controls

1.13

0.16

2.4

1.8

19.51

37.04

u/l

—

Fall on same level involving ice and snow

657

0.94

0.15

1.6

1.9

31.15

38.01

u/l

0.34

592

Superficial injury of abdomen, lower back and pelvis

140

1.14

0.15

1.9

1.8

14.06

52.38

u/l

1.33

129

Haemorrhage in early pregnancy

218

0.89

0.14

1.2

1.6

13.09

42.47

u/l

1.49

187

Substance abuse, excluding more controls

591

0.95

0.14

1.7

2.0

116.46

33.57

u/l

1.01

540

Pregnancy with abortive outcome

347

1.05

0.13

1.7

1.8

60.70

31.29

u/l

0.43

311

Sequelae of injuries of upper limb

1.18

0.12

1.3

1.9

42.97

45.19

u/l

—

Calculus of kidney and ureter

365

1.07

0.12

2.5

1.9

9.65

45.66

u/l

3.66

334

Selective serotonin reuptake inhibitors

139

709

1.03

0.11

1.9

2.0

23.48

38.84

u/l

1.42

124

646

Fracture of forearm

555

1.05

0.10

1.7

1.9

66.04

30.81

u/l

0.57

506

Impingement syndrome of shoulder

270

0.93

0.10

2.7

2.0

17.55

32.87

u/l

1.22

246

Injuries to the neck

212

1.09

0.10

2.9

1.8

12.79

41.95

u/l

1.66

196

Carpal tunnel syndrome

625

1.04

0.10

1.7

2.0

104.78

29.29

u/l

1.19

566

Other sexually transmitted chlamydial diseases

1.06

0.09

1.0

1.9

7.88

15.10

u/l

—

Endometriosis

196

1.06

0.09

1.3

1.7

39.96

28.83

u/l

0.23

176

Postprocedural disorders of nervous system

1.03

0.08

4.0

1.7

14.40

57.29

u/l

—

Disorders of vestibular function (Vertigo)

507

0.96

0.08

1.8

2.0

15.72

37.49

u/l

2.57

466

Exposure to other specified factors

802

1.03

0.07

1.9

53.05

37.82

u/l

0.33

723

Alzheimer’s disease (Atypical or mixed)

1.08

0.07

2.4

1.8

19.51

36.04

u/l

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

137

1.10

0.07

1.3

2.1

31.53

47.00

u/l

0.34

125

Postpartum haemorrhage due to retained placenta

1.03

0.07

2.1

1.5

7.59

54.11

u/l

—

Haemangioma and lymphangioma, any site

0.82

0.07

1.1

1.8

11.71

53.49

u/l

—

Other benign neoplasms of connective and other soft tissue

0.85

0.06

3.3

1.9

13.95

50.23

u/l

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

320

0.96

0.06

1.2

1.8

26.75

35.26

u/l

0.28

280

Hypertrophy of breast

142

0.92

0.06

2.1

1.6

141.51

44.98

u/l

0.33

126

Memory loss

103

0.87

0.06

1.4

1.8

28.71

63.07

u/l

—

Burns and corrosions of external body surface, specified by site

103

0.87

0.06

2.6

1.7

13.86

41.52

u/l

—

Biguanides

127

767

1.02

0.06

2.0

38.97

38.16

u/l

0.02

112

693

Dental caries 2

676

0.98

0.06

1.7

1.9

17.73

34.03

u/l

1.68

610

malignant neoplasm of male genital organs

347

0.97

0.05

2.0

2.2

42.42

44.47

u/l

0.04

318

Benign neoplasm: Stomach

100

1.10

0.05

1.8

9.19

65.05

u/l

1.59

Parodontitis or/and operation codes

461

0.98

0.04

1.8

1.9

22.06

25.81

u/l

0.29

414

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

227

1.05

0.04

1.7

1.6

44.89

33.16

u/l

0.15

207

Injuries to the elbow and forearm

727

0.98

0.03

1.7

1.9

55.28

33.32

u/l

0.42

662

Lesion of ulnar nerve

129

0.93

0.03

2.2

2.0

13.00

34.01

u/l

1.45

123

Dental caries 2 and operation codes

669

0.99

0.02

1.7

1.9

17.80

34.14

u/l

1.66

605

Coronary angioplasty

376

1.02

0.02

1.7

2.1

27.25

45.61

u/l

0.75

349

Unspecified mental disorder

439

0.98

0.02

1.5

1.8

17.83

36.43

u/l

1.57

395

Erectile dysfunction

1.08

0.02

2.0

2.2

11.28

24.13

u/l

—

Tonsillectomy and adenotomy

375

0.98

0.01

1.5

1.6

39.60

33.41

u/l

0.15

336

Endometriosis of ovary

143

1.05

0.01

1.6

1.8

68.84

30.31

u/l

—

130

Malignant neoplasm of kidney, except renal pelvis

1.06

0.01

2.2

1.9

14.95

50.27

u/l

—

Intracerebral haemorrhage

134

1.04

0.00

1.1

2.0

11.84

56.31

u/l

1.68

125

Ganglion

203

0.99

0.00

2.1

1.8

96.94

27.48

u/l

0.38

183

Pregnancy examination and test

1.04

0.00

3.5

1.3

10.67

37.06

u/l

0.77

Malignant neoplasm of urinary organs

105

1.05

0.00

2.2

1.9

17.70

46.42

u/l

0.99

Chronic diseases of tonsils and adenoids

584

1.00

0.00

1.6

2.0

29.14

41.63

u/l

0.60

520

Presbycusis

135

1.03

0.00

2.4

1.9

22.08

58.32

u/l

1.16

127

Other predominantly sexually transmitted diseases, not elsewhere classified

148

1.01

0.00

1.3

1.7

9.85

37.45

u/l

1.46

133

Spondylolisthesis/Spondylolysis

172

0.99

0.00

1.8

1.9

110.48

27.10

u/l

0.39

154

Glaucoma

584

1.01

0.00

2.0

21.45

42.47

u/l

1.86

532

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

271

1.00

0.00

1.2

1.6

125.70

35.52

u/l

0.50

248

Colon adenocarcinoma

129

1.01

0.00

1.5

2.0

17.63

59.76

u/l

1.38

120

Injury of blood vessels at neck level

0.00

0.0

1.5

—

25.50

—

Other hyperalimentation

0.00

0.0

1.6

—

17.98

—

Marasmic kwashiorkor

0.00

0.0

1.2

—

34.74

—

Sequelae of intentional self-harm, assault and events of undetermined intent

0.00

0.0

1.3

—

11.63

—

Leiomyosarcoma

0.00

0.0

1.6

—

28.18

—

Unspecified transport accident

0.00

0.0

1.4

—

9.61

—

Carcinoma in situ of vulva

0.00

0.0

1.6

—

31.08

—

Other and unspecified diseases of spleen

0.00

0.0

1.2

—

39.27

—

Abnormal reflex

0.00

0.0

1.4

—

19.36

—

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

0.00

0.0

1.8

—

18.97

—

Chronic myringitis

0.00

0.0

1.0

—

18.38

—

Congenital malformations of posterior segment of eye

0.00

0.0

1.2

—

20.72

—

Other chromosome abnormalities, not elsewhere classified

0.00

0.0

1.0

—

8.84

—

Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced

0.00

0.0

1.6

—

18.92

—

Rapidly progressive nephritic syndrome

0.00

0.0

1.4

—

9.02

—

Degenerative myopia

0.00

0.0

1.8

—

14.99

—

Senile degeneration of the brain, not elsewhere classified

0.00

0.0

1.3

—

38.37

—

Malignant neoplasm of uterus, part unspecified, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.4

—

34.68

—

Injury of blood vessels at hip and thigh level

0.00

0.0

1.4

—

31.11

—

Histrionic personality disorder

0.00

0.0

1.2

—

30.03

—

Metatarsalgia

0.96

0.00

2.0

1.9

10.85

45.75

u/l

—

Palindromic rheumatism

0.00

0.0

1.9

—

12.03

—

Corneal pigmentations and deposits

0.00

0.0

1.2

—

37.82

—

Injury of nerves at hip and thigh level

0.00

0.0

1.6

—

30.36

—

Gender identity disorders

0.00

0.0

1.3

—

22.87

—

Other/unspecified mastoiditis and related conditions

0.00

0.0

1.3

—

37.97

—

Mucinous and mucinous cystic tumor, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.7

—

216.06

—

Sunburn

0.00

0.0

1.6

—

7.74

—

Pneumonitis due to solids and liquids

0.90

0.00

1.4

1.8

40.90

59.05

u/l

—

Carcinoma in situ of vagina

0.00

0.0

1.3

—

27.96

—

Familial erythrocytosis

0.00

0.0

1.4

—

10.47

—

Benign neoplasm: Extrahepatic bile ducts

0.00

0.0

1.2

—

37.35

—

Mucinous and mucinous cystic tumor

0.00

0.0

1.3

—

36.95

—

Benign neoplasm: Connective and other soft tissue of abdomen

0.00

0.0

1.3

—

38.33

—

Other congenital malformations of intestine

0.00

0.0

1.3

—

31.96

—

Other proliferative retinopathy

0.00

0.0

1.5

—

33.43

—

Acquired pure red cell aplasia [erythroblastopenia]

0.00

0.0

1.8

—

8.92

—

Atrioventricular septal defect

0.00

0.0

1.2

—

45.34

—

Other sideroblastic anaemias

0.00

0.0

1.6

—

18.28

—

Adenocarcinoma of small intestine

0.00

0.0

1.4

—

45.84

—

Other endophthalmitis

0.00

0.0

1.7

—

15.24

—

Fractures involving multiple body regions

0.00

0.0

1.5

—

18.43

—

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

0.00

0.0

1.3

—

9.35

—

Carcinoma in situ of breast

0.00

0.0

1.4

—

295.52

—

Carcinoma in situ of breast, lobular

0.00

0.0

1.4

—

295.52

—

Other disorders of amino-acid metabolism

0.00

0.0

1.7

—

28.65

—

Contact urticaria

0.00

0.0

1.4

—

10.94

—

Chloasma

0.00

0.0

1.3

—

34.01

—

Acrodermatitis continua

0.00

0.0

1.5

—

16.77

—

Psoas tendinitis

0.00

0.0

1.7

—

9.85

—

Squamous cell neoplasms and carcinoma of cervix

0.00

0.0

1.6

—

29.41

—

Tympanosclerosis

0.00

0.0

1.2

—

39.27

—

Infliximab

0.00

0.0

1.2

—

11.85

—

Congenital hydrocephalus

0.00

0.0

1.3

—

11.10

—

Other deformity of hallux (acquired)

0.00

0.0

1.3

—

14.29

—

Enteropathogenic Escherichia coli infection

0.00

0.0

1.7

—

38.03

—

Valgus deformity, not elsewhere classified

0.00

0.0

1.3

—

130.54

—

ILD medications: acetylcysteine

0.00

0.0

1.6

—

12.91

—

Ankylosis of joint

0.00

0.0

1.6

—

17.52

—

Atlantoaxial subluxation

0.00

0.0

1.8

—

9.45

—

Drug-induced gout

0.00

0.0

1.7

—

16.43

—

Acquired clawhand, clubhand, clawfoot and clubfoot

0.00

0.0

1.2

—

18.55

—

Special screening examination for other diseases and disorders

1.00

0.00

1.0

1.4

22.86

55.76

u/l

—

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

0.00

0.0

1.0

—

38.73

—

Lichenoid drug reaction

0.00

0.0

1.3

—

37.77

—

Use of entacapone

0.00

0.0

1.6

—

31.25

—

Complex cardiac defects

0.00

0.0

1.1

—

32.31

—

Squamous cell neoplasms and carcinoma of cervix, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.3

—

247.57

—

Adrenogenital disorders

0.00

0.0

1.5

—

38.50

—

Ankyloglossia

0.00

0.0

1.4

—

12.10

—

Dyslexia and other symbolic dysfunctions, not elsewhere classified

0.00

0.0

1.3

—

17.52

—

Right side

0.00

0.0

1.3

—

27.36

—

Other enthesopathy of foot (+metatarsalgia)

0.91

0.00

2.0

1.9

10.85

43.41

u/l

—

Postinfectious hypothyroidism

0.00

0.0

1.2

—

28.01

—

Endometroid carcinoma of ovary, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.3

—

214.06

—

Other congenital malformations of heart

0.00

0.0

1.3

—

25.89

—

Malignant neoplasm of adrenal gland

0.00

0.0

1.4

—

35.00

—

Transient synovitis

0.00

0.0

1.6

—

13.06

—

Hand

0.00

0.0

1.3

—

11.24

—

Alzheimer’s disease (undefined), excluding more controls

0.00

0.0

1.3

—

116.31

—

Other and unspecified atrophic disorders of skin

0.00

0.0

1.4

—

30.59

—

Drug-induced obesity

0.00

0.0

1.6

—

23.66

—

Intentional self-harm by jumping from a high place

0.00

0.0

1.2

—

9.44

—

Congenital malformations of eyelid, lacrimal apparatus and orbit

0.00

0.0

1.4

—

30.01

—

Acne keloid

0.00

0.0

1.3

—

15.74

—

Foreign body granuloma of skin and subcutaneous tissue

0.00

0.0

1.5

—

9.38

—

Congenital malformation of optic disc

0.00

0.0

1.2

—

20.72

—

Scarlet fever

0.00

0.0

1.2

—

20.62

—

Protein-energy malnutrition of moderate and mild degree

0.00

0.0

1.9

—

30.09

—

Other congenital malformations of tongue, mouth and pharynx

0.00

0.0

1.3

—

16.56

—

Left side

0.00

0.0

1.7

—

34.26

—

Malignant neoplasm of gallbladder

0.00

0.0

1.4

—

33.63

—

Use of dimethyl fumarate

0.00

0.0

1.2

—

16.85

—

Other congenital malformations, not elsewhere classified

0.00

0.0

1.2

—

22.43

—

Other specified/unspecified diseases of inner ear

0.00

0.0

1.4

—

15.96

—

Cleft palate

0.00

0.0

1.2

—

24.80

—

Other specified and unspecified personality disorders

0.92

0.00

1.1

1.9

196.06

32.04

u/l

—

0.00

0.0

1.3

—

11.31

—

Carcinoma in situ of breast, intraductal

1.00

0.00

1.4

1.7

20.69

90.74

u/l

—

Lower leg

0.00

0.0

1.2

—

30.03

—

Mental and behavioural disorders due to hallucinogens

0.00

0.0

1.5

—

9.07

—

Mental and behavioural disorders associated with the puerperium

0.00

0.0

1.3

—

25.01

—

Malaria

0.00

0.0

1.4

—

26.83

—

Other and unspecified syphilis

0.00

0.0

1.6

—

36.86

—

Use of fingolimod

0.00

0.0

1.1

—

15.34

—

Other acquired deformities of ankle and foot

0.00

0.0

1.4

—

17.14

—

Other changes in lacrimal passages

0.00

0.0

1.4

—

17.42

—

Intrahepatic Cholestasis of Pregnancy (ICP)

1.02

0.00

1.6

1.7

12.54

71.83

u/l

—

Sleepwalking [somnambulism]

0.00

0.0

1.2

—

39.68

—

Other specified transport accidents

0.00

0.0

1.4

—

11.32

—

Carcinoma in situ of breast

0.00

0.0

1.3

—

31.76

—

Lesion of medial popliteal nerve

0.00

0.0

1.6

—

15.17

—

Hydrocephalus in other diseases

0.00

0.0

1.6

—

28.63

—

Melanoma in situ of lower limb, including hip

0.00

0.0

1.4

—

30.34

—

Transient retinal artery occlusion

0.00

0.0

1.8

—

31.13

—

Other hypertrichosis

0.00

0.0

1.0

—

43.62

—

Other specified and unspecified disorders of iris and ciliary body

0.00

0.0

1.2

—

35.72

—

Toxic erythema

0.00

0.0

1.2

—

18.57

—

Tick-borne viral encephalitis

0.00

0.0

1.7

—

38.03

—

Other infestations

0.00

0.0

1.4

—

43.80

—

Erythema in diseases classified elsewhere

0.00

0.0

1.2

—

33.42

—

Disorders of sphingolipid metabolism and other lipid storage disorders

0.00

0.0

1.7

—

29.70

—

Cholinergic urticaria

0.00

0.0

1.3

—

9.17

—

Acanthosis nigricans

0.00

0.0

1.8

—

35.44

—

Other fibroblastic disorders

0.00

0.0

1.8

—

10.98

—

Nonadministration of surgical and medical care

0.00

0.0

1.4

—

29.53

—

Brain astrocytoma, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.4

—

13.52

—

Acne varioliformis

0.00

0.0

1.0

—

46.34

—

Fall involving playground equipment

0.00

0.0

1.3

—

32.02

—

Other specified acquired deformities of limbs

0.00

0.0

1.5

—

18.70

—

Inhalation and ingestion of other objects causing obstruction of respiratory tract

0.00

0.0

1.0

—

17.06

—

Overexertion and strenuous or repetitive movements

0.90

0.00

1.3

2.0

25.64

45.67

u/l

—

Trichomoniasis

0.00

0.0

1.4

—

275.30

—

Other degenerative disorders of eyelid and periocular area

0.00

0.0

1.7

—

16.63

—

Other and unspecified localized connective tissue disorders

0.00

0.0

1.3

—

29.85

—

Haemorrhagic and haematological disorders of fetus and newborn

0.00

0.0

2.0

—

22.80

—

Thyrotoxicosis factitia

0.00

0.0

1.2

—

37.35

—

Failure in dosage during surgical and medical care

0.00

0.0

1.2

—

42.62

—

Contact with hypodermic needle

0.00

0.0

1.2

—

11.95

—

Apocrine sweat disorders, other sweat gland disorders

0.00

0.0

1.4

—

32.94

—

Changes in corneal membranes

0.00

0.0

1.4

—

18.00

—

Contact with other specified venomous animals

0.00

0.0

1.3

—

32.41

—

Other parasitologically confirmed or unspecified malaria

0.00

0.0

1.2

—

34.90

—

Other and unspecified injuries of neck

0.00

0.0

1.4

—

18.79

—

Diastasis of muscle

0.00

0.0

1.7

—

10.82

—

Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO), including avohilmo

0.00

0.0

1.2

—

11.87

—

Vaginal lichen planus

0.00

0.0

1.3

—

27.83

—

Vascular dementia (other)

0.00

0.0

1.2

—

30.53

—

Wilms' tumor

0.00

0.0

1.3

—

37.52

—

Mandibular prognathia AND surgery (LeFortI or BSSRO)

0.00

0.0

1.2

—

9.70

—

Benign neoplasm: Lower jaw bone

0.00

0.0

1.4

—

30.84

—

Benign neoplasm: Female genital organ, unspecified

0.00

0.0

1.2

—

43.60

—

Brain astrocytoma

0.00

0.0

1.3

—

11.93

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

0.96

0.00

1.6

1.5

12.54

68.60

u/l

—

Benign neoplasm: Vertebral column

0.00

0.0

1.2

—

35.94

—

Benign neoplasm: Central nervous system, other parts/unspecified

0.00

0.0

1.4

—

18.40

—

Hereditary nephropathy, not elsewhere classified

0.00

0.0

1.7

—

38.38

—

Lichen planopilaris

0.00

0.0

1.3

—

29.85

—

Malignant neoplasm of ureter

0.00

0.0

1.4

—

43.12

—

Carcinoma in situ of endometrium

0.00

0.0

1.3

—

30.06

—

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

0.00

0.0

1.4

—

26.36

—

Vascular dementia (sudden onset)

0.00

0.0

1.6

—

31.30

—

Benign neoplasm: Pelvic bones, sacrum and coccyx

0.00

0.0

1.2

—

44.02

—

Benign neoplasm: Carotid body

0.00

0.0

1.2

—

35.72

—

Factitial dermatitis

0.00

0.0

1.4

—

13.39

—

Enterobiasis

0.00

0.0

1.3

—

35.66

—

Down's syndrome

0.00

0.0

1.2

—

10.54

—

Carcinoma in situ of oral cavity, oesophagus and stomach

0.00

0.0

1.6

—

32.91

—

Carcinoma in situ of skin

0.96

0.00

1.6

1.9

43.92

77.55

u/l

—

Severe visual impairment, binocular

0.00

0.0

1.6

—

16.05

—

Alkalosis

0.00

0.0

1.6

—

32.66

—

Obstetric embolism

0.00

0.0

1.3

—

31.59

—

Tic and related disorders

0.00

0.0

1.4

—

15.89

—

Benign neoplasm: Carotid body

0.00

0.0

1.4

—

36.64

—

Benign neoplasm: Urethra

0.00

0.0

1.4

—

44.20

—

Toxic effect of corrosive substances

0.00

0.0

1.3

—

16.73

—

Symptoms and signs involving appearance and behaviour

0.00

0.0

1.6

—

6.86

—

Effects of other deprivation

0.00

-0.00

0.0

1.5

—

25.74

—

Burn and corrosion, body region unspecified

0.00

-0.00

0.0

1.7

—

10.26

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Thymidine kinase [Enzymatic activity/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS